var title_f40_25_41360="Alopecia totalis";
var content_f40_25_41360=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alopecia totalis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 422px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Complete loss of scalp hair occurs in alopecia totalis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41360=[""].join("\n");
var outline_f40_25_41360=null;
var title_f40_25_41361="Acne nodules";
var content_f40_25_41361=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acne nodules",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Severe nodular acne on the forehead.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41361=[""].join("\n");
var outline_f40_25_41361=null;
var title_f40_25_41362="Supraclavicular brachial plexus block ultrasound";
var content_f40_25_41362=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F58186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F58186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Supraclavicular brachial plexus block ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When ultrasound is used, the probe is placed in a transverse position just above the clavicle. The subclavian artery is identified by moving the transducer laterally along the clavicle and directing the transducer toward the first rib. The brachial plexus (at the level of the divisions) appears as a \"bag of grapes\" lateral to the subclavian artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41362=[""].join("\n");
var outline_f40_25_41362=null;
var title_f40_25_41363="Iodipamide meglumine: Patient drug information";
var content_f40_25_41363=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Iodipamide meglumine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/3/24627?source=see_link\">",
"     see \"Iodipamide meglumine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cholografin&reg; Meglumine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700620",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is given as a shot into a vein only.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691287",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used before an x-ray or an alike test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to iodipamide meglumine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697128",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a contrast dye allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an iodine allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703828",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have very bad kidney or liver disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697341",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have sickle cell disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025955\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696097",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you by a doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025956\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12028 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.96.59.103-93FDCDF71C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41363=[""].join("\n");
var outline_f40_25_41363=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183708\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025947\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025949\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025948\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025952\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025953\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025955\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025951\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025956\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025957\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/3/24627?source=related_link\">",
"      Iodipamide meglumine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_25_41364="Tolterodine: Patient drug information";
var content_f40_25_41364=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tolterodine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/19/14646?source=see_link\">",
"     see \"Tolterodine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/28/2502?source=see_link\">",
"     see \"Tolterodine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F230065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Detrol&reg;;",
"     </li>",
"     <li>",
"      Detrol&reg; LA",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F230066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Detrol&reg;;",
"     </li>",
"     <li>",
"      Detrol&reg; LA;",
"     </li>",
"     <li>",
"      Unidet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691716",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat an overactive bladder.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tolterodine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703505",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Trouble passing urine, glaucoma, or slow clearing of the stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man with problems passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10012488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11105 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-E13A3EE944-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41364=[""].join("\n");
var outline_f40_25_41364=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230065\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230066\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012485\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012484\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012489\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012490\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012492\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012487\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012488\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012493\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012494\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/19/14646?source=related_link\">",
"      Tolterodine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/28/2502?source=related_link\">",
"      Tolterodine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_25_41365="ECG digoxin toxicity in AF 4";
var content_f40_25_41365=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1129px;\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Single-lead electrocardiogram (ECG) showing atrial fibrillation and a junctional pacemaker with a 4:3 Wenckebach exit block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 76px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The 4 electrocardiograms in this sequence demonstrate increasing severity of digoxin toxicity in a patient with atrial fibrillation.",
"    <br>",
"     <br>",
"      In this strip, the result is group beating characterized by three beats with decreasing R-R intervals. On physical examination, this seemingly irregular rhythm might lead to the mistaken diagnosis of an irregularly irregular response to atrial fibrillation, rather than arrhythmia associated with severe digoxin toxicity. This patient presented with this ECG; the preceding electrocardiograms reflected (in reverse order) the sequence of recovery as the effect of digoxin wore off.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       The four electrocardiograms are adapted from Childers, R, Med Clin North Am 1976; 60:3.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41365=[""].join("\n");
var outline_f40_25_41365=null;
var title_f40_25_41366="Dipyridamole: Drug information";
var content_f40_25_41366=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dipyridamole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/43/23220?source=see_link\">",
"    see \"Dipyridamole: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/43/11958?source=see_link\">",
"    see \"Dipyridamole: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F161435\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Persantine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F161436\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Dipyridamole FC&reg;;",
"     </li>",
"     <li>",
"      Dipyridamole For Injection;",
"     </li>",
"     <li>",
"      Persantine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F161478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiplatelet Agent;",
"     </li>",
"     <li>",
"      Vasodilator",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F161439\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Adjunctive therapy for prophylaxis of thromboembolism with cardiac valve replacement:",
"     </b>",
"     Oral: 75-100 mg 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Evaluation of coronary artery disease:",
"     </b>",
"     I.V.: 0.14 mg/kg/minute for 4 minutes; maximum dose: 60 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Following dipyridamole infusion, inject thallium-201 within 5 minutes.",
"     <b>",
"      Note:",
"     </b>",
"     Aminophylline should be available for urgent/emergent use; dosing of 50-100 mg (range: 50-250 mg) I.V. push over 30-60 seconds.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F161457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/43/11958?source=see_link\">",
"      see \"Dipyridamole: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Adjunctive therapy for prophylaxis of thromboembolism with cardiac valve replacement:",
"     </b>",
"     Oral: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F161440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15804849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15804850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F161411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 5 mg/mL (2 mL [DSC], 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 25 mg, 50 mg, 75 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Persantine&reg;: 25 mg, 50 mg, 75 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F161396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F855061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Infuse diluted solution over 4 minutes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Administer with water 1 hour before meals.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F864340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS. Do not mix with other drugs in syringe or infusion container.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F161413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Used with warfarin to decrease thrombosis in patients after artificial heart valve replacement",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Diagnostic agent in CAD",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F7883945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stroke prevention (in combination with aspirin);",
"     <b>",
"      Note:",
"     </b>",
"     For this indication, the use of aspirin/extended release dipyridamole is recommended (Guyatt, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F161486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Dipyridamole may be confused with disopyramide",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Persantine&reg; may be confused with Periactin",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Persantine [U.S., Canada, Belgium, Denmark, France] may be confused with Permitil brand name for sildenafil [Argentina]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F161476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Oral:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Dizziness (14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distress (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Frequency not defined: Diarrhea, vomiting, flushing, pruritus, angina pectoris, liver dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Alopecia, arthritis, cholelithiasis, dyspepsia, fatigue, hepatitis, hypersensitivity reaction, hypotension, larynx edema, malaise, myalgia, nausea, palpitation, paresthesia, tachycardia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      I.V.:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Exacerbation of angina pectoris (20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness (12%), headache (12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (5%), hypertension (2%), blood pressure lability (2%), ECG abnormalities (ST-T changes, extrasystoles; 5% to 8%), pain (3%), tachycardia (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Flushing (3%), fatigue (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Dyspnea (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abdominal pain, abnormal coordination,  allergic reaction (pruritus, rash, urticaria), appetite increased, arrhythmia (ventricular tachycardia, bradycardia, AV block, SVT, atrial fibrillation, asystole), arthralgia, asthenia, back pain, breast pain, bronchospasm, cardiomyopathy, cough, depersonalization, diaphoresis, dry mouth, dysgeusia, dyspepsia, dysphagia, earache, ECG abnormalities (unspecified), edema, eructation, flatulence, hypertonia, hyperventilation, injection site reaction, intermittent claudication leg cramping, malaise, MI, myalgia, orthostatic hypotension, palpitation, perineal pain, pharyngitis, pleural pain, renal pain, rhinitis, rigor, syncope, tenesmus, thirst, tinnitus, tremor, vertigo, vision abnormalities, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F161417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dipyridamole or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F161400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with hypotension, unstable angina, and/or recent MI.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Antiplatelet agents/anticoagulants: Use with caution in patients on other antiplatelet agents or anticoagulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use of oral dipyridamole in this age group due to risk of orthostatic hypotension and availability of more efficacious alternative agents (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Injection: Severe adverse reactions have occurred rarely with I.V. administration. Use the I.V. form with caution in patients with bronchospastic disease or unstable angina. Have aminophylline ready in case of urgency or emergency with I.V. use.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F9837685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Inhibits",
"     </b>",
"     BCRP, P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F161405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: Dipyridamole may diminish the therapeutic effect of Acetylcholinesterase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adenosine: Dipyridamole may enhance the therapeutic effect of Adenosine. Dose reduction of adenosine may be needed.  Management: Reduction of the initial dose of adenosine may be warranted.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of other Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Dipyridamole may enhance the bradycardic effect of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Dabigatran dose reductions may be needed.  Specific recommendations vary considerably according to US vs Canadian labeling, specific P-gp inhibitor, renal function, and indication for dabigatran treatment.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.  Management: Increase monitoring for signs/symptoms of bleeding. The Canadian product monograph for dabigatran specifically recommends avoiding concomitant use with GIIb/IIIa inhibitors or ticlopidine, or with aspirin used for stroke prevention in atrial fibrillation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: When possible, avoid use of drotrecogin within 7 days of use of any IIb/IIIa antagonists, higher dose aspirin (more than 650 mg/day), or use of other antiplatelet agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucosamine: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. An increased risk of bleeding may occur. Nonsteroidal Anti-Inflammatory Agents may diminish the cardioprotective effect of Agents with Antiplatelet Properties. This interaction is likely specific to aspirin, and not to other antiplatelet agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Specifically, the risk of bleeding may be increased by concurrent use of these agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Prucalopride.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Regadenoson: Dipyridamole may enhance the therapeutic effect of Regadenoson.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.  Management: Avoid concurrent use of clopidogrel with rivaroxaban unless the anticipated benefits outweigh the risks of bleeding.  Avoid concurrent use of rivaroxaban with other antiplatelet agents whenever possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Silodosin: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Silodosin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: BCRP/ABCG2 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F161432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Management: Administer with water 1 hour before meals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: Many herbal medications may have additional antiplatelet activity. Management: Avoid cat's claw, dong quai, evening primrose, feverfew, garlic, ginger, ginkgo, glucosamine, omega-3-acid ethyl esters (fish oil), red clover, horse chestnut, green tea, and ginseng.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F161407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F161420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F161442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F161421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk is reported to be minimal.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F161422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken with water 1 hour before meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F161419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Dipyridamole Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/mL (2 mL): $7.58",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Dipyridamole Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (100): $58.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $94.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 mg (100): $125.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Persantine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (100): $116.02",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $186.91",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 mg (100): $250.08",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F161409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate, ECG (stress test)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F2869376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adezan (GR);",
"     </li>",
"     <li>",
"      Agremol (TH);",
"     </li>",
"     <li>",
"      Anginal (JP);",
"     </li>",
"     <li>",
"      Anti-Plate 75 (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Atrombin (FI);",
"     </li>",
"     <li>",
"      Biocardin (BG);",
"     </li>",
"     <li>",
"      Cardiwell (IN);",
"     </li>",
"     <li>",
"      Cardoxin (IL);",
"     </li>",
"     <li>",
"      Cardoxin Forte (IL);",
"     </li>",
"     <li>",
"      Cleridium (FR, PH);",
"     </li>",
"     <li>",
"      Coronair (BE);",
"     </li>",
"     <li>",
"      Dipyrol (ZA);",
"     </li>",
"     <li>",
"      Efosin (TW);",
"     </li>",
"     <li>",
"      Miosen (ES);",
"     </li>",
"     <li>",
"      Novodil (IT);",
"     </li>",
"     <li>",
"      Parotin (TW);",
"     </li>",
"     <li>",
"      Perazodin (SG);",
"     </li>",
"     <li>",
"      Persantin (AE, AR, AT, AU, BB, BD, BF, BH, BJ, BM, BR, BS, BZ, CH, CI, CL, CN, CY, CZ, DK, EE, EG, ES, ET, FI, GB, GH, GM, GN, GR, GY, HK, HN, ID, IN, IQ, IR, IT, JM, JO, KE, KP, KW, LB, LR, LY, MA, ML, MR, MT, MU, MW, MX, MY, NE, NG, NL, NO, NZ, OM, PE, PH, PK, PL, PR, PT, QA, RU, SA, SC, SD, SE, SG, SK, SL, SN, SR, SY, TN, TR, TT, TW, TZ, UG, UY, VE, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Persantin 100 (AU);",
"     </li>",
"     <li>",
"      Persantin 75 (CO);",
"     </li>",
"     <li>",
"      Persantin Depot (AT, FI);",
"     </li>",
"     <li>",
"      Persantin Forte (DE);",
"     </li>",
"     <li>",
"      Persantin PL (NZ);",
"     </li>",
"     <li>",
"      Persantin Prolonguets (PT);",
"     </li>",
"     <li>",
"      Persantin Retard (IE, NL);",
"     </li>",
"     <li>",
"      Persantin SR (AU);",
"     </li>",
"     <li>",
"      Persantine (BE, FR);",
"     </li>",
"     <li>",
"      Plato (ZA);",
"     </li>",
"     <li>",
"      PosLinlen (TW);",
"     </li>",
"     <li>",
"      Procardin (SG);",
"     </li>",
"     <li>",
"      Pytazen SR (NZ);",
"     </li>",
"     <li>",
"      Sandel (TW);",
"     </li>",
"     <li>",
"      Shengda (CL);",
"     </li>",
"     <li>",
"      Solantin (TW);",
"     </li>",
"     <li>",
"      Tovincocard (IT);",
"     </li>",
"     <li>",
"      Vasotin (ID)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F161399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits the activity of adenosine deaminase and phosphodiesterase, which causes an accumulation of adenosine, adenine nucleotides, and cyclic AMP; these mediators then inhibit platelet aggregation and may cause vasodilation; may also stimulate release of prostacyclin or PGD",
"     <sub>",
"      2",
"     </sub>",
"     ; causes coronary vasodilation",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F161416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Readily, but variable",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Adults: V",
"     <sub>",
"      d",
"     </sub>",
"     : 2-3 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 91% to 99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Terminal: 10-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 2-2.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (as glucuronide conjugates and unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/25/41366/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Anbe SC, Alpert JS, et al, &ldquo;ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 110(5):588-636.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/25/41366/abstract-text/15289388/pubmed\" id=\"15289388\" target=\"_blank\">",
"        15289388",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bell AD, Roussin A, Cartier R, et al, &ldquo;The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines,&rdquo;",
"      <i>",
"       Can J Cardiol",
"      </i>",
"      , 2011, 27(Suppl A):1-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/25/41366/abstract-text/21640290/pubmed\" id=\"21640290\" target=\"_blank\">",
"        21640290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ferraris VA, Saha SP, Oestreich JH, et al, &ldquo;2012 Update to the Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2012, 94(5):1761-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/25/41366/abstract-text/23098967/pubmed\" id=\"23098967\" target=\"_blank\">",
"        23098967",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guyatt GH, Akl EA, Crowther M, et al, &ldquo;Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):7-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/25/41366/abstract-text/22315257/pubmed\" id=\"22315257\" target=\"_blank\">",
"        22315257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stanek EJ, Melko GP, and Charland SL, \"Xanthine Interference With Dipyridamole-Thallium-201 Myocardial Imaging,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1995, 29(4):425-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/25/41366/abstract-text/7633022/pubmed\" id=\"7633022\" target=\"_blank\">",
"        7633022",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stein PD, Schunemann HJ, Dalen JE, et al, &ldquo;Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2004, 126(3 Suppl):600-08.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9377 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-A93D27A9D4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41366=[""].join("\n");
var outline_f40_25_41366=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161435\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161436\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161478\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161439\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161457\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161440\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15804849\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15804850\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161411\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161396\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F855061\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F864340\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161413\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7883945\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161486\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161476\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161417\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161400\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9837685\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161405\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161432\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161407\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161420\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161442\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161421\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161422\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161419\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161409\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2869376\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161399\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161416\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9377\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9377|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?22/43/23220?source=related_link\">",
"      Dipyridamole: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/43/11958?source=related_link\">",
"      Dipyridamole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_25_41367="Antibiotic prophylaxis for gastrointestinal endoscopic procedures";
var content_f40_25_41367=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Antibiotic prophylaxis for gastrointestinal endoscopic procedures",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41367/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41367/contributors\">",
"     George W Meyer, MD, FACP, MACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41367/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41367/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41367/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41367/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/25/41367/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value of antibiotic prophylaxis for gastrointestinal (GI) procedures has been debated for many years. Previously, antibiotic prophylaxis was recommended for many GI procedures in patients with high-risk cardiac conditions to protect against infective endocarditis. However, practices have substantially changed, in part due to the low incidence of infective endocarditis following GI procedures and the lack of controlled data supporting the benefit of antibiotic prophylaxis. Furthermore, the indiscriminate use of antibiotics can be associated with the development of resistant organisms, Clostridium difficile colitis, unnecessary expense, and drug toxicity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/18/36137?source=see_link&amp;anchor=H5#H5\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\", section on 'Antibiotics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recommendations for antibiotic prophylaxis prior to GI procedures for endocarditis and other indications will be reviewed here. General issues related to prophylaxis for bacterial endocarditis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MAJOR SOCIETY GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Updated guidelines for antibiotic prophylaxis were published in 2007 and 2008 by the American Heart Association (AHA) and the American Society for Gastrointestinal Endoscopy (ASGE), respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The recommendations in these guidelines are largely consistent with one another, but substantially different from prior guidelines. These recommendations, as well as specific antibiotic regimens, are discussed in detail below and summarized in the tables (",
"    <a class=\"graphic graphic_table graphicRef51133 \" href=\"mobipreview.htm?30/19/31037\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54121 \" href=\"mobipreview.htm?13/60/14285\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The largest change is that both guidelines",
"    <strong>",
"     no longer",
"    </strong>",
"    consider any gastrointestinal procedure high risk for bacterial endocarditis and therefore do not recommend routine use of endocarditis prophylaxis, even in patients with the highest risk cardiac conditions (such as prosthetic valves or prior endocarditis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections following endoscopic procedures are rare and are presumably the result of bacteremia induced during the procedure or, in the case of procedures such as pancreatic cyst aspiration, the result of inoculation with bacteria during the procedure.",
"   </p>",
"   <p>",
"    Bacteremia results from translocation of endogenous bacteria into the blood stream via mucosal trauma, whereas inoculation of sterile tissues or spaces (eg, cysts) occurs from direct contact with a contaminated endoscope or endoscopic accessory. Contrast injection may also result in bacteria being introduced into a previously sterile space (eg, the biliary tree during ERCP).",
"   </p>",
"   <p>",
"    The concern with regard to bacteremia is that the bacteria may colonize a remote site, such as a diseased heart valve or a prosthetic joint, resulting in infection. However, it is likely that this is",
"    <strong>",
"     not",
"    </strong>",
"    a significant problem with regard to gastrointestinal (GI) procedures.",
"   </p>",
"   <p>",
"    As an example, there is only a weak association of GI procedures with infective endocarditis and data are lacking to support a causal link [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. A 2003 literature review found only 15 reported cases of endocarditis following endoscopic procedures, which included esophageal dilation, sclerotherapy, gastroscopy, sigmoidoscopy, and colonoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, antibiotic prophylaxis has not been shown to prevent endocarditis following GI procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     RATES OF BACTEREMIA AND INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rates of bacteremia following gastrointestinal (GI) procedures are generally lower than those seen following routine daily activities such as eating, and rarely result in clinically evident infection. Furthermore, bacteremia due to organisms capable of causing endocarditis occurs in less than 5 to 10 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Routine activities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient bacteremia is commonly seen following routine daily activities, with rates as high as 68 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"     2",
"    </a>",
"    ]. Some activities associated with bacteremia include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Brushing and flossing &ndash; 20 to 68 percent",
"     </li>",
"     <li>",
"      Using toothpicks &ndash; 20 to 40 percent",
"     </li>",
"     <li>",
"      Chewing food &ndash; 7 to 51 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These observations should be considered when evaluating the incidence of transient bacteremia associated with GI endoscopic procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     High-risk procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following endoscopic procedures are considered high-risk for bacteremia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dilation of an esophageal stricture &ndash; The risk of bacteremia with esophageal bougienage has been estimated to be 12 to 22 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]. Factors that may increase the risk include multiple passes of the dilator and dilation of malignant strictures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Treatment of esophageal varices &ndash; The mean reported rate of bacteremia is 15 percent (range 0 to 52 percent) with sclerotherapy and 9 percent (range 1 to 25 percent) following endoscopic variceal ligation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Endoscopic retrograde cholangiopancreatography (ERCP) &ndash; The risk of bacteremia with ERCP depends upon whether the bile duct is obstructed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/3,6\">",
"       3,6",
"      </a>",
"      ]. In one review, the rate was 6 percent in the absence of obstruction and 18 percent in the presence of obstruction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/3\">",
"       3",
"      </a>",
"      ]. The incidence of cholangitis is also increased in patients with obstruction. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23959?source=see_link\">",
"       \"Post-ERCP septic complications\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other procedures are considered high-risk for infection unrelated to bacteremia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopic ultrasound with fine-needle aspiration (EUS-FNA) &ndash; The reported rate of bacteremia associated with EUS-FNA ranges from 4 to 6 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"       2",
"      </a>",
"      ], making it a low-risk procedure with regard to bacteremia. However, the overall infection risk is probably higher. The risk of infection depends upon the type of lesion being sampled. Limited data suggest that solid lesions are low-risk for infection (0.01 to 2 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2,7\">",
"       2,7",
"      </a>",
"      ]. The risk of infection following EUS-FNA of cystic lesions is less clear, with reported rates ranging from less than 1 percent to 14 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2,8\">",
"       2,8",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Antibiotic prophylaxis may decrease the risk of infection in patients undergoing EUS-FNA of cystic lesions. In a study in which 90 percent of 603 patients undergoing EUS-FNA of pancreatic cysts received antibiotic prophylaxis, only one patient became infected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/9\">",
"       9",
"      </a>",
"      ]. However, a retrospective study that compared 178 patients who underwent EUS-FNA of pancreatic cysts without antibiotic prophylaxis with 88 patients who did receive antibiotic prophylaxis found that the rate of infection was very low, regardless of whether antibiotics were given (one transient fever in the group that did not receive antibiotics, one cyst infection in the group that received antibiotics, and one case of Clostridium difficile in the group that received antibiotics) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Percutaneous endoscopic gastrostomy (PEG) &ndash; In a Cochrane analysis of 10 randomized trials of 1100 patients undergoing PEG placement, patients who received antibiotic prophylaxis had a significant reduction in peristomal infections compared to those who did not receive prophylactic antibiotics (14 versus 33 percent, pooled odds ratio 0.31) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Low-risk procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine upper endoscopy, colonoscopy, and flexible sigmoidoscopy are all considered to be low-risk procedures with regard to bacteremia and infection. As noted in the American Society for Gastrointestinal Endoscopy guidelines, the mean reported rate of bacteremia was 4.4 percent for both gastroscopy without biopsy and colonoscopy and 0 to 1 percent for flexible sigmoidoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     WHEN TO USE ANTIBIOTIC PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations for antibiotic prophylaxis are based upon the risks related to specific procedures, as well as patient factors that may predispose to infection.",
"   </p>",
"   <p>",
"    A summary of the American Heart Association (AHA) and the American Society for Gastrointestinal Endoscopy (ASGE) guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], as well as specific antibiotic regimens, are presented in Tables 1 and 2 (",
"    <a class=\"graphic graphic_table graphicRef51133 \" href=\"mobipreview.htm?30/19/31037\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54121 \" href=\"mobipreview.htm?13/60/14285\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     PEG placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics have been recommended for all patients prior to placement of a percutaneous gastrostomy (PEG) tube since they can substantially reduce the risk of peristomal wound infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Patients are typically given",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    (1 g IV) or an equivalent antibiotic 30 minutes prior to the procedure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The emergence of methicillin-resistant Staphylococcus aureus as a major pathogen causing PEG-site infections in some centers has raised concerns about the effectiveness of prophylaxis with cephalosporins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/12\">",
"     12",
"    </a>",
"    ]. The ASGE guidelines recommend preprocedural screening for MRSA in locales where MRSA is endemic and attempting decontamination before placing the feeding tube [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/59/17338?source=see_link&amp;anchor=H9#H9\">",
"     \"Prevention and control of methicillin-resistant Staphylococcus aureus in adults\", section on 'Decolonization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cardiac conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain cardiac lesions such as prosthetic valves or prior endocarditis (",
"    <a class=\"graphic graphic_table graphicRef51133 \" href=\"mobipreview.htm?30/19/31037\">",
"     table 1",
"    </a>",
"    ) have been classified as high-risk for infective endocarditis for some procedures (eg, dental work). However, they are",
"    <strong>",
"     not",
"    </strong>",
"    considered indications for antibiotic prophylaxis for gastrointestinal (GI) procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. While some endoscopists elect to give antibiotics to patients with prosthetic valves or those who have previously had endocarditis, there are no good data to support either giving or withholding antibiotics in these situations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=see_link&amp;anchor=H14#H14\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\", section on 'Genitourinary and gastrointestinal tracts'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, the American Heart Association guidelines recommend that antimicrobial prophylaxis only be given to patients with high-risk heart valve lesions if they undergo procedures that are likely to result in bacteremia with a microorganism that has the potential ability to cause endocarditis. They do not consider any GI procedure high-risk for bacteremia with microorganisms that can cause endocarditis and therefore do not recommend the routine use of antibiotic prophylaxis, even in patients with high-risk valvular lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A potential source of confusion and concern for some patients with cardiac lesions is that they may have been told that they must have antibiotic prophylaxis for all procedures. We recommend that patients be reassured that these recommendations come from both the American Society for Gastrointestinal Endoscopy and the American Heart Association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Major society guidelines'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Bile duct obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic prophylaxis is recommended prior to ERCP in patients with biliary obstruction AND cholangitis, or in patients with biliary obstruction that is unlikely to be drained successfully at ERCP (such as patients with malignant hilar obstruction or primary sclerosing cholangitis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2,13\">",
"     2,13",
"    </a>",
"    ]. In contrast, antibiotics are not recommended in patients with biliary obstruction when complete biliary drainage is anticipated.",
"   </p>",
"   <p>",
"    In addition, patients with inadequate endoscopic biliary drainage following ERCP should receive antibiotics due to the high risk of cholangitis. Once drainage has been established, antibiotics can be discontinued if there is no evidence of cholangitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibiotics should cover enteric gram-negative organisms and enterococci.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     Ciprofloxacin",
"    </a>",
"    (500 mg orally given 30 to 60 minutes prior to the procedure or 400 mg IV given within 30 minutes prior to the procedure) is commonly used and has the advantages of oral or IV administration as well as low cost [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/14\">",
"     14",
"    </a>",
"    ]. However, ciprofloxacin activity against enterococci is moderate and patients who are at elevated risk of infectious complications, or where there is evidence of ciprofloxacin resistance, should receive",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1160?source=see_link\">",
"     ampicillin-sulbactam",
"    </a>",
"    (3 grams IV within 30 minutes prior to the procedure) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    (875 mg orally 30 to 60 minutes prior to the procedure) in addition to, or as an alternative to, ciprofloxacin.",
"   </p>",
"   <p>",
"    Other alternatives include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"       Ampicillin",
"      </a>",
"      (adult 2 g, child 50",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV) plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      (1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      not to exceed 120 mg IV) 30 minutes before the procedure.",
"     </li>",
"     <li>",
"      In penicillin allergic patients,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (adult 1 g, child 15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV) plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      (1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      not to exceed 120 mg IV) 30 minutes before the procedure can be used. Vancomycin should be infused slowly over 60 to 90 minutes to conclude within 30 minutes before the procedure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/59/1978?source=see_link&amp;anchor=H2#H2\">",
"       \"Vancomycin hypersensitivity\", section on 'Red man syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cystic and solid lesions along the GI tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics are generally recommended for patients with sterile pancreatic cystic lesions who are undergoing ERCP or endoscopic ultrasound with fine-needle aspiration (EUS-FNA), to reduce the risk of cyst infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/15\">",
"     15",
"    </a>",
"    ]. However, the data supporting the use of antibiotics in this setting are weak, and until data support antibiotic use, we believe it is reasonable to not give antibiotics to patients with pancreatic cysts who are undergoing endoscopic ultrasound with fine-needle aspiration (EUS-FNA) or endoscopic retrograde cholangiopancreatography. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'High-risk procedures'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition, the American Society for Gastrointestinal Endoscopy (ASGE) guidelines recommend administration of antibiotics for EUS-FNA of cystic lesions outside the pancreas, but not for solid lesions in the upper GI tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"     2",
"    </a>",
"    ]. The ASGE guidelines do not make a recommendation with regard to antibiotic prophylaxis for EUS-FNA of solid lesions in the lower GI tract and there are few data to recommend prophylactic antibiotics in this situation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/7\">",
"     7",
"    </a>",
"    ]. Until data suggest an increased risk of infection, it is our recommendation that antibiotics",
"    <strong>",
"     not",
"    </strong>",
"    be given for routine biopsy of solid lesions of the lower GI tract.",
"   </p>",
"   <p>",
"    As with bile duct obstruction, antibiotics should cover biliary flora (such as enteric gram-negative organisms, enterococci, and possibly Pseudomonas sp). Fluoroquinolones, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    (500 mg orally given 30 to 60 minutes prior to the procedure or 400 mg IV given within 30 minutes prior to the procedure), are often used. The antibiotic is given before the procedure and often continued for three to five days after the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cirrhosis with acute GI bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic prophylaxis for patients with cirrhosis and acute GI bleeding is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/56/1928?source=see_link\">",
"     \"General principles of the management of variceal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Cirrhosis with ascites and immunocompromised patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data are available to guide recommendations on antibiotic prophylaxis for patients with cirrhosis and ascites and for patients with other causes of immunocompromise (including those on high doses of glucocorticoids) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Antibiotic prophylaxis should be considered on an individual basis in patients undergoing GI procedures associated with a high risk of bacteremia, but not with low-risk procedures. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'High-risk procedures'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H7\">",
"     'Low-risk procedures'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Antibiotic regimens for general prophylaxis include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Patients not allergic to penicillin",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"       Amoxicillin",
"      </a>",
"      (adult 2 g, child 50",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      orally 30 to 60 minutes before the procedure; a postprocedure dose is not necessary.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"       Ampicillin",
"      </a>",
"      (adult 2 g",
"      <span class=\"nowrap\">",
"       IV/IM,",
"      </span>",
"      child 50",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      within 30 minutes before the procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These regimens give protection up to two hours after the procedure is started [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Patients allergic to penicillin",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      (adult 600 mg, child 20",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      orally 30 to 60 minutes before the procedure or IV within 30 minutes before the procedure.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/37/37462?source=see_link\">",
"       Cephalexin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/7/10357?source=see_link\">",
"       cefadroxil",
"      </a>",
"      (adult 2 g, child 50",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      orally 30 to 60 minutes before the procedure. However, cephalosporins should NOT be given to patients with serious reactions to penicillin including hives, throat tightening, or anaphylaxis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23274?source=see_link\">",
"       \"Allergy to penicillins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"       Cefazolin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (adult 1 g, child 50",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      IM or IV within 30 minutes before procedure. However, cephalosporins should",
"      <strong>",
"       not",
"      </strong>",
"      be given to patients with serious reactions to penicillin including hives, throat tightening, or anaphylaxis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23274?source=see_link\">",
"       \"Allergy to penicillins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       Azithromycin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      (adult 500 mg, child 15",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      orally 30 to 60 minutes before the procedure.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      (adults 1 g, children 15",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      IV infused slowly over 60 to 90 minutes to avoid an anaphylactoid reaction and timed to conclude within 30 minutes before procedure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/59/1978?source=see_link&amp;anchor=H2#H2\">",
"       \"Vancomycin hypersensitivity\", section on 'Red man syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Synthetic vascular grafts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both the American Heart Association (AHA) and American Society for Gastrointestinal Endoscopy (ASGE) guidelines concluded that antibiotics are not necessary in patients with vascular grafts that have been in place for at least six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, the AHA, but not the ASGE, recommends antibiotic prophylaxis for procedures within the first six months of graft placement to permit time for endothelialization of the graft. The ASGE does not recommend prophylaxis, citing evidence that no infection of a graft has been associated with endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"     2",
"    </a>",
"    ]. It is our practice",
"    <strong>",
"     not",
"    </strong>",
"    to give antibiotic prophylaxis to such patients more than six months following graft placement.",
"   </p>",
"   <p>",
"    If the decision is made to give prophylactic antibiotics, one of the regimens for general prophylaxis should be used. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Cirrhosis with ascites and immunocompromised patients'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Nonvalvular cardiovascular devices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic prophylaxis is",
"    <strong>",
"     not",
"    </strong>",
"    recommended for patients with nonvalvular cardiovascular devices such as pacemakers, defibrillators, and cardiac stents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Prosthetic joints",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Orthopedic Surgeons (AAOS) recommends that clinicians consider antibiotic prophylaxis for patients with prosthetic joint replacements prior to any invasive procedure that may cause bacteremia.",
"    <strong>",
"    </strong>",
"    Their recommendations can be found at",
"    <a class=\"external\" href=\"file://www.aaos.org/about/papers/advistmt/1033.asp\">",
"     file://www.aaos.org/about/papers/advistmt/1033.asp",
"    </a>",
"    . However, there are no data suggesting that gastrointestinal procedures are associated with an increased risk of infection in patients with prosthetic joints. As a result, antibiotic prophylaxis is not recommended by the ASGE or the American Society of Colon and Rectal surgeons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2,18\">",
"     2,18",
"    </a>",
"    ]. A letter to the editor of Gastrointestinal Endoscopy recommends not giving antibiotics unless specifically requested by the patient. Our approach to a patient whose surgeon has recommended antibiotics is to discuss the issue with the patient. If the patient still wishes to receive antibiotics after the discussion, we will give them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Peritoneal dialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ASGE offers no specific recommendations regarding antibiotic prophylaxis in patients undergoing peritoneal dialysis. However, there have been several case reports of peritonitis in such patients following colonoscopy, particularly after polypectomy (presumably because of bacterial translocation into the peritoneal cavity) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no definitive data to guide decisions, but a working group recommended that the abdomen be emptied of fluid prior to any procedure involving the abdomen or pelvis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/23\">",
"     23",
"    </a>",
"    ]. In addition, antibiotic prophylaxis has been recommended by the International Society for Peritoneal Dialysis (ISPD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41367/abstract/23\">",
"     23",
"    </a>",
"    ] for patients undergoing colonoscopy with polypectomy. ISPD recommends",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    (adult 1 g) plus a single dose of an aminoglycoside (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    1.5",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    not to exceed 120 mg), with or without",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    (500 mg), given IV just prior to the procedure.",
"   </p>",
"   <p>",
"    However, while we think it is reasonable to perform the colonoscopy when the peritoneum is empty, we believe that there are not enough data to recommend routine prophylactic antibiotics for patients receiving peritoneal dialysis who are undergoing colonoscopy with polypectomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26248?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathophysiology and prevention of peritonitis in peritoneal dialysis\", section on 'Prophylactic antibiotic administration for procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Procedures that are considered high-risk for bacteremia include esophageal dilation, treatment of esophageal varices, and endoscopic retrograde cholangiopancreatography (ERCP) in patients with obstructed bile ducts. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'High-risk procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of patients undergoing endoscopic procedures do not require antibiotic prophylaxis.",
"     </li>",
"     <li>",
"      Valvular heart disease (including the highest-risk valve conditions, such as a prosthetic valve) is no longer an indication for antibiotic prophylaxis for GI procedures. While some endoscopists elect to give antibiotics to patients with prosthetic valves or those who have previously had endocarditis, there are no good data to support either giving or withholding antibiotics in these situations. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Cardiac conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend antibiotic prophylaxis for all patients undergoing percutaneous endoscopic gastrostomy tube placement (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'PEG placement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that patients with pancreatic cysts undergoing endoscopic ultrasound with fine-needle aspiration (EUS-FNA) or ERCP",
"      <strong>",
"       not",
"      </strong>",
"      receive prophylactic antibiotics (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We believe there are insufficient data to support their use in this setting. However, since the data regarding the potential benefits and harms of prophylactic antibiotics in such patients are inconclusive, giving prophylactic antibiotics is a reasonable alternative, especially if the cyst is not fully aspirated, and is consistent with the 2008 American Society of Gastrointestinal Endoscopy guidelines. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Cystic and solid lesions along the GI tract'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest antibiotic prophylaxis for EUS-FNA of cystic lesions anywhere along the GI tract, but not for solid lesions of the upper or lower GI tract (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Cystic and solid lesions along the GI tract'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibiotics are recommended for patients with cirrhosis and variceal bleeding, regardless of whether an endoscopy is performed. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/56/1928?source=see_link\">",
"       \"General principles of the management of variceal hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that patients with biliary obstruction that is unlikely to be successfully drained endoscopically receive antibiotic prophylaxis prior to undergoing ERCP (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Bile duct obstruction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is controversy between the American Academy of Orthopedic Surgeons and the American Society for Gastrointestinal Endoscopy about antibiotic prophylaxis for patients with orthopedic prostheses who undergo endoscopic procedures. There are no data to support the need for antibiotics in these situations.",
"     </li>",
"     <li>",
"      We do not suggest prophylactic antibiotics for patients receiving peritoneal dialysis who are undergoing colonoscopy with planned polypectomy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, it is reasonable to drain the peritoneum before performing colonoscopy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26248?source=see_link&amp;anchor=H8#H8\">",
"       \"Pathophysiology and prevention of peritonitis in peritoneal dialysis\", section on 'Prophylactic antibiotic administration for procedures'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H20\">",
"       'Peritoneal dialysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The American Society for Gastrointestinal Endoscopy and American Heart Association recommendations for antibiotic prophylaxis for gastrointestinal procedures, as well as specific antibiotic regimens, are summarized in the tables (",
"      <a class=\"graphic graphic_table graphicRef51133 \" href=\"mobipreview.htm?30/19/31037\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef54121 \" href=\"mobipreview.htm?13/60/14285\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/1\">",
"      Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/2\">",
"      ASGE STANDARDS OF PRACTICE COMMITTEE, Banerjee S, Shen B, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008; 67:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/3\">",
"      Nelson DB. Infectious disease complications of GI endoscopy: Part I, endogenous infections. Gastrointest Endosc 2003; 57:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/4\">",
"      Zuccaro G Jr, Richter JE, Rice TW, et al. Viridans streptococcal bacteremia after esophageal stricture dilation. Gastrointest Endosc 1998; 48:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/5\">",
"      Nelson DB, Sanderson SJ, Azar MM. Bacteremia with esophageal dilation. Gastrointest Endosc 1998; 48:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/6\">",
"      Cotton PB, Connor P, Rawls E, Romagnuolo J. Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc 2008; 67:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/7\">",
"      Levy MJ, Norton ID, Clain JE, et al. Prospective study of bacteremia and complications With EUS FNA of rectal and perirectal lesions. Clin Gastroenterol Hepatol 2007; 5:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/8\">",
"      Guarner-Argente C, Shah P, Buchner A, et al. Use of antimicrobials for EUS-guided FNA of pancreatic cysts: a retrospective, comparative analysis. Gastrointest Endosc 2011; 74:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/9\">",
"      Lee LS, Saltzman JR, Bounds BC, et al. EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol 2005; 3:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/10\">",
"      Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev 2006; :CD005571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/11\">",
"      Jafri NS, Mahid SS, Minor KS, et al. Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy. Aliment Pharmacol Ther 2007; 25:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/12\">",
"      Chaudhary KA, Smith OJ, Cuddy PG, Clarkston WK. PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol 2002; 97:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/13\">",
"      Thompson BF, Arguedas MR, Wilcox CM. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost? Aliment Pharmacol Ther 2002; 16:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/14\">",
"      Subhani JM, Kibbler C, Dooley JS. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999; 13:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/15\">",
"      Jacobson BC, Baron TH, Adler DG, et al. ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc 2005; 61:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/16\">",
"      Bianco JA, Pepe MS, Higano C, et al. Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients. Am J Med 1990; 89:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/17\">",
"      Kaw M, Przepiorka D, Sekas G. Infectious complications of endoscopic procedures in bone marrow transplant recipients. Dig Dis Sci 1993; 38:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/18\">",
"      Oliver G, Lowry A, Vernava A, et al. Practice parameters for antibiotic prophylaxis--supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 2000; 43:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/19\">",
"      Settles D, Rex DK. Antibiotics before endoscopy in patients with prosthetic joints. Gastrointest Endosc 2011; 73:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/20\">",
"      Bac DJ, van Blankenstein M, de Marie S, Fieren MW. Peritonitis following endoscopic polypectomy in a peritoneal dialysis patient: the need for antibiotic prophylaxis. Infection 1994; 22:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/21\">",
"      Ray SM, Piraino B, Holley J. Peritonitis following colonoscopy in a peritoneal dialysis patient. Perit Dial Int 1990; 10:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/22\">",
"      Petersen JH, Weesner RE, Giannella RA. Escherichia coli peritonitis after left-sided colonoscopy in a patient on continuous ambulatory peritoneal dialysis. Am J Gastroenterol 1987; 82:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41367/abstract/23\">",
"      Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2545 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-794AB5B1AF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41367=[""].join("\n");
var outline_f40_25_41367=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MAJOR SOCIETY GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      RATES OF BACTEREMIA AND INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Routine activities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      High-risk procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Low-risk procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      WHEN TO USE ANTIBIOTIC PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PEG placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cardiac conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Bile duct obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cystic and solid lesions along the GI tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cirrhosis with acute GI bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Cirrhosis with ascites and immunocompromised patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Patients not allergic to penicillin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Patients allergic to penicillin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Synthetic vascular grafts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Nonvalvular cardiovascular devices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Prosthetic joints",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2545\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2545|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/19/31037\" title=\"table 1\">",
"      ASGE guidelines Abx prophylxs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/60/14285\" title=\"table 2\">",
"      Abx prophylaxis regimens",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23274?source=related_link\">",
"      Allergy to penicillins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/18/36137?source=related_link\">",
"      Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/56/1928?source=related_link\">",
"      General principles of the management of variceal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26248?source=related_link\">",
"      Pathophysiology and prevention of peritonitis in peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/63/28666?source=related_link\">",
"      Post-ERCP pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23959?source=related_link\">",
"      Post-ERCP septic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/59/17338?source=related_link\">",
"      Prevention and control of methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/59/1978?source=related_link\">",
"      Vancomycin hypersensitivity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_25_41368="Approach to the young athlete with neck pain or injury";
var content_f40_25_41368=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the young athlete with neck pain or injury",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     Jason E Decker, MD, FAAP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     Albert C Hergenroeder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     Joseph Chorley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41368/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/25/41368/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trauma to the neck of a young athlete may injure the cervical spine, the neck vessels, and the aerodigestive tract. Because of the vital importance of these structures, athletes with complaints of neck pain or injury must be thoroughly evaluated so that appropriate management and referral decisions can be made.",
"   </p>",
"   <p>",
"    The anatomy of the cervical spine and the diagnostic approach to the young athlete with complaints of neck pain or injury will be discussed here. The care of the athlete with an acute neck injury and specific cervical spine injuries are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/28/15815?source=see_link\">",
"     \"Field care and evaluation of the young athlete with acute neck injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11033?source=see_link\">",
"     \"Overview of musculoskeletal neck injuries in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A basic understanding of cervical spine anatomy is critical to the evaluation and management of the young athlete with complaints of neck pain or injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Cervical spine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main function of the vertebral column is to protect the spinal cord. The vertebrae of the cervical spine are smaller and more delicate than those of the thoracic and lumbar spine. Nonetheless, during contact-collision sports, the cervical spine may be required to dissipate axial forces that are several times the individual player's body weight.",
"   </p>",
"   <p>",
"    The first two cervical vertebrae are specialized bones that function as an important unit. The atlas (C1) articulates with the occiput of the skull superiorly and with the axis (C2) inferiorly (",
"    <a class=\"graphic graphic_figure graphicRef66846 \" href=\"mobipreview.htm?20/10/20640\">",
"     figure 1",
"    </a>",
"    ). Approximately 50 percent of cervical spine motion occurs at these two joints [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The atlanto-occipital joint permits the majority of flexion and extension, whereas the atlantoaxial joint permits the majority of rotation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/3\">",
"     3",
"    </a>",
"    ]. Varying amounts of flexion, extension, lateral bending, and rotation occur from C3 through C7. In the child older than eight years and in the adult, flexion is centered in the area of C5-C6, and extension in the area of C6-C7 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/1\">",
"     1",
"    </a>",
"    ]. These areas are particularly vulnerable to injuries and degenerative changes.",
"   </p>",
"   <p>",
"    The vertebral bodies make up the anterior aspect of the spinal column. A bony lip on the lower surface of the vertebral body forms the uncovertebral joint with the adjacent vertebra. Below C2, the intervertebral discs separate the vertebral bodies and provide cushion and flexibility to the vertebral column.",
"   </p>",
"   <p>",
"    The anterior and posterior longitudinal ligaments stabilize the vertebral bodies. The posterior vertebral column consists of the pedicles, laminae, facets, and spinous processes. The facet joints, which are true synovial joints, comprise the posterior articulations of the vertebrae. The posterior column is stabilized by the nuchal ligament complex (supraspinous, interspinous, and infraspinous ligaments), the capsular ligaments, and the ligamentum flavum. Disruption of these ligaments results in cervical spine instability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Spinal cord and nerves",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spinal cord originates from the medulla oblongata and continues caudally through the vertebral foramina until it terminates in the lumbar area. The spinal cord possesses three main tracts, the location and function of which are important in the evaluation of patients with spinal cord injuries (",
"    <a class=\"graphic graphic_figure graphicRef71763 \" href=\"mobipreview.htm?43/15/44275\">",
"     figure 2",
"    </a>",
"    ). These tracts include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The posterior columns, which carry fine touch, vibration sense, proprioception, and pressure from the ipsilateral side",
"     </li>",
"     <li>",
"      The corticospinal tract, which lies in the posterolateral spinal cord and carries motor fibers to the ipsilateral side of the body",
"     </li>",
"     <li>",
"      The spinothalamic tract, which is located in the anterolateral spinal cord and carries pain and temperature fibers from the contralateral side of the body",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Paired spinal nerve roots, which contain the motor and sensory neurons, exit from the spinal cord at each vertebral level via the intervertebral foramina. There are eight pairs of cervical spinal nerves, which are named for the vertebral body above which they exit. C5, for example, exits above the fifth vertebra. The exception is the C8 nerve root, which exits between the C7 and T1 vertebrae. Spinal nerves are subject to local pressure phenomena from herniated discs or narrowing of the foramen, which can produce neurologic symptoms in the distribution of the affected nerve.",
"   </p>",
"   <p>",
"    The sensory cervical dermatomes are illustrated in the figure (",
"    <a class=\"graphic graphic_figure graphicRef53006 \" href=\"mobipreview.htm?21/8/21634\">",
"     figure 3",
"    </a>",
"    ). The biceps and brachioradialis reflexes are mediated by the C5-6 roots, and the triceps reflex by the C6-7 roots (mainly C7). Peripheral motor innervation from the cervical spine is as follows (",
"    <a class=\"graphic graphic_table graphicRef63597 \" href=\"mobipreview.htm?23/43/24253\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      C3-C5 innervate the diaphragm; respiratory paralysis may be present with injuries above C4",
"     </li>",
"     <li>",
"      C5 innervates the deltoid and biceps muscles",
"     </li>",
"     <li>",
"      C6 innervates the wrist extensors and abductor and extensors of the thumb",
"     </li>",
"     <li>",
"      C7 innervates the triceps, wrist flexors, and finger extensors",
"     </li>",
"     <li>",
"      C8 innervates the finger flexors",
"     </li>",
"     <li>",
"      T1 innervates the intrinsic hand muscles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The brachial plexus is a complex network of neurons formed primarily by the roots of the fifth through eighth cervical nerves and the first thoracic nerve (",
"    <a class=\"graphic graphic_figure graphicRef50576 \" href=\"mobipreview.htm?34/25/35222\">",
"     figure 4",
"    </a>",
"    ). It lies in the lateral part of the neck in the clavicular region, extending from the scalenus anterior to the axilla [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/4\">",
"     4",
"    </a>",
"    ]. The brachial plexus supplies motor and sensory innervation to the upper limb and limb girdle. Its location in the neck makes it particularly susceptible to traction and compression during contact-collision sports.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Muscles",
"    </span>",
"    &nbsp;&mdash;&nbsp;The muscles of the neck may be categorized into anterior and posterior anatomic divisions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Anterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anterior division includes the platysma, sternocleidomastoid, anterior vertebral muscles, and the lateral vertebral muscles (",
"    <a class=\"graphic graphic_figure graphicRef76977 graphicRef56033 \" href=\"mobipreview.htm?10/45/10970\">",
"     figure 5A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The platysma is the most superficial muscle in the anterior neck. It is a broad, thin muscle that overlies the other muscles and neck structures.",
"     </li>",
"     <li>",
"      The sternocleidomastoid arises from the sternum and the medial third of the clavicle, and passes obliquely across the side of the neck to insert into the mastoid process. It flexes, laterally bends, and rotates the neck.",
"     </li>",
"     <li>",
"      The anterior vertebral muscles, which have attachments to the vertebrae and occipital region of the skull, assist the sternocleidomastoid in neck flexion, rotation, and lateral bending. They include the longus colli, longus capitis, rectus capitis anterior, and rectus capitis lateralis (",
"      <a class=\"graphic graphic_figure graphicRef76977 graphicRef56033 \" href=\"mobipreview.htm?10/45/10970\">",
"       figure 5A-B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The lateral vertebral muscles, or the scalene muscles, attach from the cervical vertebrae to the first or second ribs (",
"      <a class=\"graphic graphic_figure graphicRef76977 graphicRef56033 \" href=\"mobipreview.htm?10/45/10970\">",
"       figure 5A-B",
"      </a>",
"      ). They act as weak movers of the neck, and are also accessory muscles of respiration. The nerves of the brachial plexus pass between the anterior and middle scalene muscles en route to the subclavian area.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Posterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;The muscles of the posterior division include the trapezius, splenius capitis, semispinalis capitis, and levator scapulae (",
"    <a class=\"graphic graphic_figure graphicRef56552 \" href=\"mobipreview.htm?27/15/27903\">",
"     figure 6",
"    </a>",
"    ). The posterior muscle groups maintain posture and act as neck stabilizers and extensors. They are stronger than the anterior groups.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The trapezius is the flat, triangular muscle that covers the posterior portion of the neck, shoulders, and thorax. It originates in the occiput, nuchal ligament, spinous processes of C7-T12, and the supraspinal ligaments. It inserts into the lateral clavicle, acromion, and scapular spine. In addition to its role in the maintenance of cervical posture, it is an important scapular mover and stabilizer.",
"     </li>",
"     <li>",
"      The splenius capitis and semispinalis capitis arise from the lower cervical and upper thoracic vertebrae and insert at the base of the skull.",
"     </li>",
"     <li>",
"      The levator scapulae originates in the upper four cervical vertebrae and inserts into the superomedial corner of the scapula.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Vasculature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important vessels in the neck include the common carotid arteries, vertebral arteries, jugular veins, and vertebral veins. The common carotid arteries originate in the great vessels in the chest and course superiorly, lateral to the esophagus and trachea. At the level of the hyoid bone, the common carotid branches into the internal and external carotid arteries, which supply blood to the brain, head, and some neck structures (",
"    <a class=\"graphic graphic_figure graphicRef58024 \" href=\"mobipreview.htm?1/32/1540\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The vertebral arteries arise from the subclavian arteries. They angle backwards to the transverse processes of C6 and run superiorly through the transverse foramina of C6-C1 to the inferior surface of the skull [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/4\">",
"     4",
"    </a>",
"    ]. The vertebral arteries join together at the base of the brain to form the basilar artery. Damage to the vertebral arteries associated with cervical spine or neck trauma can result in disability or death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The jugular and vertebral veins drain blood from the cranial cavity, face, and neck. The internal jugular vein courses from the sigmoid sinus of the brain to the subclavian veins, lying just lateral to the carotid arteries. The external jugular veins begin at the parotid gland, cross superficially over the sternocleidomastoid, and empty into the subclavian vein. They can be seen readily in many people. The vertebral veins travel with the vertebral arteries through the transverse foramina of the first six cervical vertebrae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other structures",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the cervical spine and neck vessels, the neck contains other important structures, including the larynx, trachea, esophagus, and thyroid gland. The larynx and trachea are situated anteriorly in the midline of the neck. The larynx contains cartilage that protects the airway and the vocal cords from injury. Additional structural support is provided by the trachea's C-shaped rings of cartilage and the hyoid bone, located in the anterior neck between the chin and the larynx. Trauma to any of these structures may result in airway compromise.",
"   </p>",
"   <p>",
"    The esophagus is located behind the trachea and retropharyngeal space. The retropharyngeal space is a fascial plane that is continuous with the mediastinum. This anatomic relationship is important in cases of penetrating trauma to the esophagus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    retropharyngeal space because of the potential for direct spread of microorganisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The annual incidence of traumatic spinal cord injury is estimated to be between 30 and 46 cases per million population in the United States and Canada [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. The majority of injuries occur in young adults: 57 percent of cases occur in people 16 to 30 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/9\">",
"     9",
"    </a>",
"    ]. Among children and adolescents, the risk of acute cervical spine injury increases with age (13.2 versus 1.2 per 100,000 population per year among those older and younger than 11 years, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/10\">",
"     10",
"    </a>",
"    ]. Most injuries (&gt;80 percent) occur in males.",
"   </p>",
"   <p>",
"    Motor vehicle accidents account for approximately 35 percent of spinal cord injuries. The next most common causes, in descending order, are gunshot wounds, falls, and recreational sporting activities. Sports and recreational activities account for between 5 and 14 percent of spinal cord injuries, most of which involve the cervical spine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk for serious injury in sports increases with age, since larger, stronger, and faster participants are able to deliver greater forces to the head and neck area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/12\">",
"     12",
"    </a>",
"    ]. Adolescents are more likely than younger children to sustain fractures and injuries to the lower cervical spine, whereas younger children more often sustain ligamentous injuries and injuries to the upper cervical spine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/7/32889?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\", section on 'Anatomic considerations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The injuries that occur in organized sports tend to receive the greatest attention. However, a large number of sports-related spinal injuries occur during unsupervised activities, such as swimming, diving, surfing, cycling, skiing, trampoline use, and various winter sports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/1,13-17\">",
"     1,13-17",
"    </a>",
"    ]. These injuries are more sporadic and probably underreported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/12\">",
"     12",
"    </a>",
"    ]. Diving accounts for up to 75 percent of recreation-related spinal cord injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/18\">",
"     18",
"    </a>",
"    ], most of which occur at C5 and result in quadriplegia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/17,19\">",
"     17,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the United States, the youth sports with the highest risk for head and spine injuries include football, gymnastics, cheerleading, and ice hockey [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Because more children participate in football than in the other sports, the absolute numbers of severe injuries are highest in football [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/21\">",
"     21",
"    </a>",
"    ]. Other sports with high risk for head and spine injury are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef77373 \" href=\"mobipreview.htm?30/31/31227\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The incidence of catastrophic cervical spine injuries in high school football players has declined significantly over the past three decades to the current estimate of 1 cervical spine injury per 100,000 athletes or about six high school players sustaining catastrophic cervical spine injuries annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The reduction is thought to be related to increased emphasis on safety measures, including prohibition of initial contact with the head in blocking and tackling, football helmet standards, improved medical care for the injured athlete, and improved coaching methods in teaching the fundamental skills of blocking and tackling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of neck pain and injury should include a complete history, physical examination, and various imaging studies.",
"   </p>",
"   <p>",
"    The prehospital evaluation and management of the athlete with an acutely injured neck are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/28/15815?source=see_link\">",
"     \"Field care and evaluation of the young athlete with acute neck injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cervical spine must be immobilized in any child who is suspected of having a cervical spine injury (",
"    <a class=\"graphic graphic_table graphicRef76379 \" href=\"mobipreview.htm?20/20/20811\">",
"     table 3",
"    </a>",
"    ) until the injury is excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/27\">",
"     27",
"    </a>",
"    ]. Immobilization should be established in the prehospital setting, or failing that, upon presentation to the health care facility. Immobilization should be continued until injury is ruled out clinically or radiographically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/27\">",
"     27",
"    </a>",
"    ]. The major concern in athletes with cervical spine injuries is the possibility of an unstable fracture that may produce quadriplegia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/44/6854?source=see_link\">",
"     \"Pediatric cervical spine immobilization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should encompass the chief complaint, a full characterization of neck pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    associated symptoms, the mechanism of injury, past medical history (particularly regarding injuries and medications), and review of systems. The characterization of pain should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The exact location of the pain or numbness, and whether there is any radiation",
"     </li>",
"     <li>",
"      The onset of pain (eg, slow and insidious or after a traumatic episode)",
"     </li>",
"     <li>",
"      The nature of pain (eg, burning, tingling, tightness)",
"     </li>",
"     <li>",
"      Aggravating and relieving factors (eg, movement, posture)",
"     </li>",
"     <li>",
"      Temporal patterns (association with work, activities, particular time of day)",
"     </li>",
"     <li>",
"      Associated symptoms (headache, neck stiffness, upper-extremity paresthesia, numbness, or weakness)",
"     </li>",
"     <li>",
"      Shoulder or upper-extremity pain (may indicate cervical spinal cord or nerve root pathology)",
"     </li>",
"     <li>",
"      Previous evaluation and treatment, and whether treatment helped to relieve symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The nature of the pain may give some insight into the diagnosis. Burning pain or paresthesias suggest a neurologic condition, whereas neck tightness and spasm is usually a musculoskeletal problem (possibly a fracture), and may be the only sign of an unstable fracture. Upper-extremity symptoms suggest neurologic injury or disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11033?source=see_link\">",
"     \"Overview of musculoskeletal neck injuries in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Mechanism of injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of injury and position of the head during the event can help narrow the differential diagnosis by suggesting the path through which force is dissipated, as described below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/12,21\">",
"     12,21",
"    </a>",
"    ]. Eyewitness reports or videotapes of the injury may help determine the mechanism of injury.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flexion injuries compress the anterior elements and disrupt the posterior elements. Potential injuries include anterior wedge vertebral body fractures, chip fractures, anterior dislocations, rupture of the posterior ligaments or ligamentum flavum, and rupture of the posterior half of the disc. In addition to the above, combined flexion-rotation injuries can cause anterior subluxation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11033?source=see_link\">",
"       \"Overview of musculoskeletal neck injuries in the young athlete\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Extension injuries compress the posterior elements and disrupt the anterior elements. Potential injuries include posterior bony injury to the spinous processes, facets, and neural arch, and rupture of the anterior longitudinal ligament and anterior disc. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11033?source=see_link\">",
"       \"Overview of musculoskeletal neck injuries in the young athlete\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When the head is in the neutral position, with the normal cervical lordotic curve, forces transmitted to the head are dissipated in the cervical muscles (",
"      <a class=\"graphic graphic_figure graphicRef82225 \" href=\"mobipreview.htm?24/11/24752\">",
"       figure 8",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/12\">",
"       12",
"      </a>",
"      ]. When the neck is flexed to 30 degrees, the cervical spine is straight; forces transmitted to the head are minimally dissipated to the cervical muscles and directly transmitted from one vertebra to the next. If the impact force is greater than the strength of the bone, a compression fracture may result [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/19\">",
"       19",
"      </a>",
"      ]. Compression injuries include vertebral end-plate fractures, or propulsion of the vertebra and disc into the spinal canal. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11033?source=see_link\">",
"       \"Overview of musculoskeletal neck injuries in the young athlete\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link\">",
"       \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Neck examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination is essential in narrowing the diagnostic possibilities. A careful examination, coupled with an understanding of the neck anatomy, can help determine which structures are responsible for the patient's symptoms. The examination should include inspection, palpation, active range of motion, passive range of motion, strength testing, and",
"    <span class=\"nowrap\">",
"     special/provocative",
"    </span>",
"    tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Inspection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inspection of the neck should be performed from the anterior, posterior, and lateral views. The patient's posture should be noted, as should any rotational deformity or muscle atrophy. Absence of the normal cervical lordosis suggests spasm of the neck muscles. Any abnormalities should be further evaluated radiographically. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Radiologic evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful palpation of the neck structures helps to identify subtle deformities (eg, facet dislocation). Point tenderness of the spinous processes, particularly with a recent history of trauma, implies a bony abnormality such as a vertebral fracture. If muscle spasm is present, identification of the involved muscle(s) can provide important clues about the underlying problem. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Anatomy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Range of motion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of the patient's range of motion is a vital portion of the neck examination. Active range of motion should always be assessed before attempting provocative maneuvers that require passive range of motion.",
"   </p>",
"   <p>",
"    Active range of motion for cervical flexion, extension, lateral bending, and lateral rotation should be assessed. Limitation in range of motion or poor segmental spinal movement suggests underlying pathology.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flexion-extension: Ask the patient to touch the chin to the chest and then to look up at the ceiling. The sternocleidomastoid muscles are the primary flexors, the paravertebral extensor and trapezius are the primary extensors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Lateral bending: Ask the patient to touch the ear to the ipsilateral shoulder without raising the shoulder. Normal range of lateral bending is approximately 45 degrees; the primary lateral benders are the scaleni anterior, medial, and posterior [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Lateral rotation: Ask the patient to twist the chin toward the right and left. Normal range of rotation is 60 to 80 degrees; the sternocleidomastoid muscles are the primary rotators [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Passive range of motion is evaluated with the patient supine and awake. Manipulation of the cervical spine should not occur in an unconscious patient. The examiner should gently hold the head between his or her hands while an assistant steadies the shoulders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Strength testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neck muscles should be tested for strength in all directions (ie, flexion, extension, lateral bending, and rotation). Strength testing is particularly important when muscle wasting is present and in evaluating whether the athlete may return to play.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Special tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Special or provocative tests that help to identify the etiology of symptoms in the neck include the axial compression test, Spurling test, and the distraction test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To execute the axial compression test, with the patient in the seated or standing position, the examiner places his or her hands on top of the patient's head and applies a compressive force inferiorly. A positive test reproduces pain or radicular symptoms, implying nerve root compression.",
"     </li>",
"     <li>",
"      The Spurling or neck compression test is a variant of the axial compression test in which the patient's neck is extended and rotated toward the involved side as the axial load is applied (",
"      <a class=\"graphic graphic_picture graphicRef52401 \" href=\"mobipreview.htm?11/45/11999\">",
"       picture 1",
"      </a>",
"      ). This neck position narrows the intervertebral foramina on the affected side and reproduces the radiating pain if there is pathology at the root or foramen [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/29\">",
"       29",
"      </a>",
"      ]. This maneuver is highly specific for the presence of cervical root compression, but the sensitivity is low [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/30\">",
"       30",
"      </a>",
"      ]. Thus, a positive test is helpful, but a negative test does not rule out radiculopathy.",
"     </li>",
"     <li>",
"      Manual cervical traction (the distraction test) is used to confirm the diagnosis of radiculopathy. Vertical traction is gently applied to the seated or supine patient's head (",
"      <a class=\"graphic graphic_picture graphicRef61568 \" href=\"mobipreview.htm?36/40/37519\">",
"       picture 2",
"      </a>",
"      ). Because this maneuver reduces pressure at the level of the disk and facet joints, symptoms due to compressed nerve roots may be temporarily relieved.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Neurologic examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Every patient with neck pain should have a neurologic examination to determine whether a neurologic deficit is present, and if so, its distribution. Neurologic signs can occur in patterns that suggest a central lesion, a nerve root radiculopathy, or peripheral nerve entrapment. A thorough understanding of the neuroanatomy, including the sensory and motor dermatomes of the upper extremities, is necessary to localize the lesion (",
"    <a class=\"graphic graphic_table graphicRef63597 \" href=\"mobipreview.htm?23/43/24253\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef53006 \" href=\"mobipreview.htm?21/8/21634\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Spinal cord and nerves'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A detailed neurologic examination should be performed in any patient presenting with signs or symptoms consistent with a neck injury. The examination should include upper-extremity strength testing, assessment of reflexes and sensation, and testing for upper motor neuron function. Depending upon the history, cranial nerve evaluation also may be appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14618?source=see_link&amp;anchor=H10928992#H10928992\">",
"     \"Detailed neurologic assessment of infants and children\", section on 'Neurologic examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     RADIOLOGIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Athletes with suspected cervical spine injury must undergo radiologic evaluation. At a minimum, simple radiologic evaluation must include three views (cross-table lateral view, anteroposterior (AP), and open-mouth odontoid view). Computed tomography (CT) evaluation and magnetic resonance imaging (MRI) also may be indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/7/32889?source=see_link\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The historical and physical findings that direct radiologic evaluation are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef79881 \" href=\"mobipreview.htm?9/11/9405\">",
"     table 4",
"    </a>",
"    ). Among athletes, injuries sustained in diving, falls from a distance greater than the athlete's height, and axial compression injuries are considered to be high-risk injuries. The radiographic evaluation of the cervical spine is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/7/32889?source=see_link\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The three-view cervical spine series is usually sufficient if the athlete's symptoms are limited to pain and rigidity and promptly resolve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/31\">",
"     31",
"    </a>",
"    ]. However, if the athlete has symptoms that suggest spinal cord involvement (eg, transient quadriplegia, burning hands syndrome, or other bilateral motor or sensory symptoms, (",
"    <a class=\"graphic graphic_table graphicRef76379 \" href=\"mobipreview.htm?20/20/20811\">",
"     table 3",
"    </a>",
"    )), even if such symptoms are transient, an MRI should be obtained to evaluate the spinal cord. Children with neck trauma who have a normal physical examination and normal cervical spine radiographs may have significant spinal cord injury. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4951?source=see_link&amp;anchor=H26107906#H26107906\">",
"     \"Spinal cord injury without radiographic abnormality (SCIWORA) in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Contrast-enhanced CT and myelography, which are invasive and not usually necessary after MRI, may be indicated in select cases. Contrast-enhanced CT is more sensitive than MRI for evaluating fractures and bony abnormalities, and myelography provides a better view of spinal cord compression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate surgical services (eg, neurosurgery, orthopedics) should be consulted to direct the management of athletes in whom cervical spine injuries are detected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Methylprednisolone",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/63/17401?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    in patients with spinal cord injury is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/11/26810?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute traumatic spinal cord injury\", section on 'Glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     RETURN TO PLAY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decisions regarding return to play must be made on a case-by-case basis, particularly for contact-collision sports. The safety of the athlete is the most important consideration in making the decision, and the decision-making process should involve consultation with members of the specialty teams who have participated in the athlete's care (eg, neurosurgery, orthopedics, sports medicine, physical therapy).",
"   </p>",
"   <p>",
"    As a general rule, athletes who have unstable injuries should be prohibited from returning to play. Additional contraindications to participation include injuries resulting in permanent central nervous system dysfunction, permanent and significant peripheral nerve root dysfunction, and spinal fusion above the C-5 level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, athletes with stable fractures, stable ligamentous injuries, and stable one-level surgical fusions can usually participate after appropriate treatment and rehabilitation. Stability of the cervical spine should be assessed with dynamic (ie, flexion-extension) radiographs, and clearance from the athlete's neurosurgeon should be obtained before participation is permitted. Athletes with cervical burners may return to play when completely asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/33\">",
"     33",
"    </a>",
"    ], whereas return to play for those who have transient quadriplegia (cervical cord neurapraxia) is controversial. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11033?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of musculoskeletal neck injuries in the young athlete\", section on 'Subluxation and dislocation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\", section on 'Cervical burners'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\", section on 'Cervical cord neurapraxia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One author has categorized cervical spine conditions and injuries into three groups: no contraindication, relative contraindication, and absolute contraindication to participation in contact sports (",
"    <a class=\"graphic graphic_table graphicRef65756 graphicRef77229 \" href=\"mobipreview.htm?39/55/40830\">",
"     table 5A-B",
"    </a>",
"    ). The recommendations are based upon information compiled from the National Football Head and Neck Injury Registry (including more than 1200 cervical spine injuries), literature review, and the author's experience and understanding of pathophysiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these recommendations, and the existence of other sets of guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/35,36\">",
"     35,36",
"    </a>",
"    ] controversy remains regarding return to play for athletes with borderline injuries",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    conditions for which available data are inadequate for decision-making (eg, cervical spinal stenosis with transient quadriplegia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41368/abstract/31,34\">",
"     31,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\", section on 'Cervical cord neurapraxia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/31/23026?source=see_link\">",
"       \"Patient information: Neck pain (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/45/17106?source=see_link\">",
"       \"Patient information: Whiplash (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/35/27188?source=see_link\">",
"       \"Patient information: Neck pain (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10072008\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the United States, the youth sports with the highest risk for head and spine injuries include American football, gymnastics, cheerleading, and ice hockey. Because more children participate in football than in the other sports, the absolute numbers of severe injuries are highest in football. Diving accounts for up to 75 percent of recreation-related spinal cord injuries, most of which occur at C5 and result in quadriplegia. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The cervical spine must be immobilized in any child who is suspected of having a cervical spine injury until the injury is excluded (",
"      <a class=\"graphic graphic_table graphicRef77373 \" href=\"mobipreview.htm?30/31/31227\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef76379 \" href=\"mobipreview.htm?20/20/20811\">",
"       table 3",
"      </a>",
"      ). Immobilization should be established in the prehospital setting, or failing that, upon presentation to the health care facility. Immobilization should be continued until injury is ruled out clinically or radiographically. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/28/15815?source=see_link\">",
"       \"Field care and evaluation of the young athlete with acute neck injury\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The history should encompass the chief complaint, a full characterization of neck pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      associated symptoms, the mechanism of injury, and past medical history (particularly prior injuries). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A careful physical examination, coupled with an understanding of the neck anatomy, can help determine which structures are responsible for the patient's symptoms. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Neck examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neurologic signs can occur in patterns that suggest a central lesion, a nerve root radiculopathy, or peripheral nerve entrapment. A thorough understanding of the neuroanatomy, including the sensory and motor dermatomes of the upper extremities, is necessary to localize the lesion (",
"      <a class=\"graphic graphic_table graphicRef63597 \" href=\"mobipreview.htm?23/43/24253\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53006 \" href=\"mobipreview.htm?21/8/21634\">",
"       figure 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Neurologic examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The historical and physical findings that direct radiologic evaluation are summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef79881 \" href=\"mobipreview.htm?9/11/9405\">",
"       table 4",
"      </a>",
"      ). Among athletes, injuries sustained in diving, falls from a distance greater than the athlete's height, and axial compression injuries are considered to be high-risk injuries. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Radiologic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The three-view cervical spine series is usually sufficient if the athlete's symptoms are limited to pain and rigidity and promptly resolve. However, if the athlete has symptoms that suggest spinal cord involvement (eg, transient quadriplegia, burning hands syndrome, or other bilateral motor or sensory symptoms (",
"      <a class=\"graphic graphic_table graphicRef76379 \" href=\"mobipreview.htm?20/20/20811\">",
"       table 3",
"      </a>",
"      )), even if such symptoms are transient, then an MRI is warranted to evaluate the spinal cord. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Radiologic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appropriate surgical services (eg, neurosurgery, orthopedics) should be consulted to direct the management of athletes in whom cervical spine injuries are detected. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Reid, DC. Sports Injury Assessment and Rehabilitation, Churchill Livingstone, New York 1992. p.739.",
"    </li>",
"    <li>",
"     Tachdjian, MO. The neck and upper limb. In: Clinical Pediatric Orthopedics: The Art of Diagnosis and Principles of Management, Appleton and Lange, Stamford 1997. p.263.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/3\">",
"      Aptaker, RL. Neck pain. Part 1: Narrowing the differential. Phys Sportsmed 1997; 24.",
"     </a>",
"    </li>",
"    <li>",
"     Clemente, CD. Gray's Anatomy, 13th ed, Lea and Febiger, Philadelphia 1984.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/5\">",
"      Rontoyannis GP, Pahtas G, Dinis D, Pournaras N. Sudden death of a young wrestler during competition. Int J Sports Med 1988; 9:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/6\">",
"      Lasfargues JE, Custis D, Morrone F, et al. A model for estimating spinal cord injury prevalence in the United States. Paraplegia 1995; 33:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/7\">",
"      Johnson RL, Gabella BA, Gerhart KA, et al. Evaluating sources of traumatic spinal cord injury surveillance data in Colorado. Am J Epidemiol 1997; 146:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/8\">",
"      Dryden DM, Saunders LD, Rowe BH, et al. The epidemiology of traumatic spinal cord injury in Alberta, Canada. Can J Neurol Sci 2003; 30:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/9\">",
"      Little, NE. In case of a broken neck. Emerg Med 1989; 21:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/10\">",
"      McGrory BJ, Klassen RA, Chao EY, et al. Acute fractures and dislocations of the cervical spine in children and adolescents. J Bone Joint Surg Am 1993; 75:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/11\">",
"      Schmitt H, Gerner HJ. Paralysis from sport and diving accidents. Clin J Sport Med 2001; 11:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/12\">",
"      Proctor MR, Cantu RC. Head and neck injuries in young athletes. Clin Sports Med 2000; 19:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/13\">",
"      Maroon JC, Bailes JE. Athletes with cervical spine injury. Spine (Phila Pa 1976) 1996; 21:2294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/14\">",
"      Brown PG, Lee M. Trampoline injuries of the cervical spine. Pediatr Neurosurg 2000; 32:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/15\">",
"      Noguchi T. A survey of spinal cord injuries resulting from sport. Paraplegia 1994; 32:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/16\">",
"      Bailes JE, Herman JM, Quigley MR, et al. Diving injuries of the cervical spine. Surg Neurol 1990; 34:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/17\">",
"      Good RP, Nickel VL. Cervical spine injuries resulting from water sports. Spine (Phila Pa 1976) 1980; 5:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/18\">",
"      Kewalramani LS, Orth MS, Taylor RG. Injuries to the cervical spine from diving accidents. J Trauma 1975; 15:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/19\">",
"      Torg JS. Epidemiology, pathomechanics, and prevention of athletic injuries to the cervical spine. Med Sci Sports Exerc 1985; 17:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/20\">",
"      Cantu RC, Mueller FO. Fatalities and catastrophic injuries in high school and college sports, 1982-1997 lessons for improving safety. Phys Sportsmed 1999; 27:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/21\">",
"      Cantu RC. Head and spine injuries in youth sports. Clin Sports Med 1995; 14:517.",
"     </a>",
"    </li>",
"    <li>",
"     www.unc.edu/depts/nccsi (Accessed on August 13, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/23\">",
"      Bailes JE, Petschauer M, Guskiewicz KM, Marano G. Management of cervical spine injuries in athletes. J Athl Train 2007; 42:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/24\">",
"      Boden BP, Tacchetti RL, Cantu RC, et al. Catastrophic cervical spine injuries in high school and college football players. Am J Sports Med 2006; 34:1223.",
"     </a>",
"    </li>",
"    <li>",
"     Mueller, FO, Cantu, RC. National Center for Catastrophic Sport Injury Research. Twenty-second Annual Report: Fall 1982-Spring 2004. June 2005. www.unc.edu/depts/nccsi/AllSport.htm (Accessed on January 18, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/26\">",
"      Cantu RC, Mueller FO. Catastrophic football injuries: 1977-1998. Neurosurgery 2000; 47:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/27\">",
"      Skellett S, Tibby SM, Durward A, Murdoch IA. Lesson of the week: Immobilisation of the cervical spine in children. BMJ 2002; 324:591.",
"     </a>",
"    </li>",
"    <li>",
"     Reider, BR. The Orthopaedic Physical Examination, WB Saunders, Philadelphia 1999. p.301.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/29\">",
"      Leffert RD. Nerve lesions about the shoulder. Orthop Clin North Am 2000; 31:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/30\">",
"      Viikari-Juntura E, Porras M, Laasonen EM. Validity of clinical tests in the diagnosis of root compression in cervical disc disease. Spine (Phila Pa 1976) 1989; 14:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/31\">",
"      Cantu RC. The cervical spinal stenosis controversy. Clin Sports Med 1998; 17:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/32\">",
"      Ghiselli G, Schaadt G, McAllister DR. On-the-field evaluation of an athlete with a head or neck injury. Clin Sports Med 2003; 22:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/33\">",
"      Cantu RC. Cervical spine injuries in the athlete. Semin Neurol 2000; 20:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/34\">",
"      Meredith RM, Butcher JD. Field splinting of suspected fractures: preparation, assessment, and application. Phys Sportsmed 1997; 25:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/35\">",
"      Vaccaro AR, Watkins B, Albert TJ, et al. Cervical spine injuries in athletes: current return-to-play criteria. Orthopedics 2001; 24:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41368/abstract/36\">",
"      Cantu RC, Bailes JE, Wilberger JE Jr. Guidelines for return to contact or collision sport after a cervical spine injury. Clin Sports Med 1998; 17:137.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6516 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-109.224.62.197-1340D11401-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41368=[""].join("\n");
var outline_f40_25_41368=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10072008\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Cervical spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Spinal cord and nerves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Muscles",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Anterior",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Posterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Vasculature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other structures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Mechanism of injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Neck examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Inspection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Palpation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Range of motion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Strength testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Special tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Neurologic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      RADIOLOGIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Methylprednisolone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      RETURN TO PLAY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10072008\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6516\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6516|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/10/20640\" title=\"figure 1\">",
"      Atlantoaxial anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/15/44275\" title=\"figure 2\">",
"      Cervical spinal cord anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/8/21634\" title=\"figure 3\">",
"      Cervical dermatomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/25/35222\" title=\"figure 4\">",
"      Trunks and cords of the brachial plexus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/26/19876\" title=\"figure 5A\">",
"      Anterior neck muscles A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/32/29191\" title=\"figure 5B\">",
"      Anterior neck muscles B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/15/27903\" title=\"figure 6\">",
"      Posterior neck muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/32/1540\" title=\"figure 7\">",
"      Arteries of the neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/11/24752\" title=\"figure 8\">",
"      C-spine axial load",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6516|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/45/11999\" title=\"picture 1\">",
"      Spurling test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/40/37519\" title=\"picture 2\">",
"      Manual vertical traction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6516|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/43/24253\" title=\"table 1\">",
"      Neurologic deficits in spinal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/31/31227\" title=\"table 2\">",
"      High risk sports spine injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/20/20811\" title=\"table 3\">",
"      Signs and symptoms of spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/11/9405\" title=\"table 4\">",
"      Radiologic evaluation of the C spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/5/29789\" title=\"table 5A\">",
"      Return to play guidelines A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/33/31261\" title=\"table 5B\">",
"      Return to play guidelines B",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/11/26810?source=related_link\">",
"      Acute traumatic spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14618?source=related_link\">",
"      Detailed neurologic assessment of infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/7/32889?source=related_link\">",
"      Evaluation of cervical spine injuries in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/28/15815?source=related_link\">",
"      Field care and evaluation of the young athlete with acute neck injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23689?source=related_link\">",
"      Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/49/11033?source=related_link\">",
"      Overview of musculoskeletal neck injuries in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/35/27188?source=related_link\">",
"      Patient information: Neck pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/31/23026?source=related_link\">",
"      Patient information: Neck pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/45/17106?source=related_link\">",
"      Patient information: Whiplash (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/44/6854?source=related_link\">",
"      Pediatric cervical spine immobilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4951?source=related_link\">",
"      Spinal cord injury without radiographic abnormality (SCIWORA) in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_25_41369="Prevention of dementia";
var content_f40_25_41369=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention of dementia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     Daniel Press, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     Michael Alexander, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     Steven T DeKosky, MD, FAAN",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/25/41369/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/25/41369/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia is an increasing problem, primarily affecting elderly patients. Alzheimer disease (AD) is the most common form of dementia in the elderly, accounting for 60 to 80 percent of cases. Asymptomatic patients often present with concerns about developing dementia, especially when they have a family history.",
"   </p>",
"   <p>",
"    While an analysis based upon the observed prevalence of potentially modifiable risk factors (hypertension, diabetes, inactivity) combined with their associated relative risk for dementia suggests that risk factor reductions of 10 to 25 percent may prevent up to half of AD cases, this has not as yet been supported by empirical data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/1\">",
"     1",
"    </a>",
"    ]. At the present time, evidence is lacking to support the routine use of any of these measures for the specific indication of preventing AD or dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Related material concerning risk factors for dementia is discussed separately. The risk factors, treatment, and prevention of vascular dementia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/22/36202?source=see_link\">",
"     \"Risk factors for dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/57/37786?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of vascular dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/55/10104?source=see_link\">",
"     \"Treatment and prevention of vascular dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The recognition and evaluation of dementia is discussed separately. The major types of dementia and the treatment of dementia are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=see_link\">",
"     \"Evaluation of cognitive impairment and dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33865?source=see_link\">",
"     \"Treatment of dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/57/37786?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of vascular dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/33/27162?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Alzheimer disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1914?source=see_link\">",
"     \"Clinical features and diagnosis of dementia with Lewy bodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VITAMIN SUPPLEMENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Antioxidant vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some studies suggest that oxidative stress may be important in the pathogenesis of Alzheimer disease (AD):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The brains of patients with AD contain lesions that are typically associated with free radical exposure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The brains of patients with AD contain elevated levels of endogenous antioxidants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Exogenous antioxidants reduce the toxicity of beta-amyloid in in-vitro studies of brains of patients with AD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings have led to interest in assessing the role of antioxidants (eg, vitamin E,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    , flavonoids, vitamin C) for the prevention of AD. Data from the Alzheimer's Disease Cooperative Study has suggested that the antioxidant vitamin E may be beneficial in slowing the progression of disease in patients with established AD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33865?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of dementia\", section on 'Vitamin E and selegiline'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of antioxidants for prevention of dementia has been evaluated in several observational studies with varying results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/8-17\">",
"     8-17",
"    </a>",
"    ]. While two large, prospective cohort studies reported that higher dietary intake of antioxidants was associated with a lower risk of AD, these studies had significant limitations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. As an example, the use of a food frequency questionnaire to estimate nutrient intake may have limited accuracy in patients with cognitive dysfunction. Also, neither study found an association between antioxidant supplements and AD risk; only antioxidant intake from food affected outcomes. Other studies have not found an association between dietary antioxidant intake and the development of AD or cognitive impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/14,16\">",
"     14,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of large randomized clinical trials of vitamin E supplementation in older individuals (men and women) with normal cognition or mild cognitive impairment have shown no impact of treatment on cognitive change over follow-up times that have ranged from 7 to 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. While there may be a role for vitamin E in treating patients with established AD, there is not convincing evidence that it can delay the onset of the disease.",
"   </p>",
"   <p>",
"    Supplementation with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    , another antioxidant, was studied in a subset of 4052 patients enrolled in the Physicians' Health Study who agreed to re-enroll in a follow-up study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/22\">",
"     22",
"    </a>",
"    ]. While the investigators reported a benefit in cognitive scores for individuals receiving long-term supplementation (18 years) compared to those on placebo, methodological issues with this study cast doubt on the validity of these findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In summary, there are no convincing data to suggest that the intake of antioxidants can prevent AD. Since there is growing concern regarding the risk of vitamin E supplementation (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"     \"Vitamin supplementation in disease prevention\"",
"    </a>",
"    ), we do not recommend supplementation with Vitamin E or other antioxidants for the prevention of AD or other types of dementia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Vitamins B6, B12, and folate",
"    </span>",
"    &nbsp;&mdash;&nbsp;While there is some evidence that elevated serum homocysteine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    low serum levels of folate, vitamin B6, and vitamin B12 may be associated with impaired cognition and risk of dementia, there are no convincing data that vitamin supplementation prevents dementia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/22/36202?source=see_link&amp;anchor=H417059#H417059\">",
"     \"Risk factors for dementia\", section on 'Homocysteine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A possible benefit from folate therapy was suggested in a longitudinal (nonrandomized) study of 965 older individuals, in which a lower incidence of AD was noted among those in the highest quartile of total folate intake after adjustments for age, sex, education, ethnicity, and other comorbidities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/24\">",
"     24",
"    </a>",
"    ]. Neither vitamin B6 nor B12 intake was associated with risk of AD.",
"   </p>",
"   <p>",
"    Published trials of vitamin supplementation in older adults have yielded somewhat mixed results. Treatment durations are relatively short. In addition, the outcome is often measured by performance on cognitive tests rather than the by the incidence of dementia. Study populations have also varied with respect to baseline cognition and age.",
"   </p>",
"   <p>",
"    Examples of longer-term, double-blind randomized studies include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A trial in 276 healthy adults over 65 years with elevated serum homocysteine found that supplementation with folate and vitamins B12 and B6 was not associated with improved cognitive performance after two years, despite the fact that homocysteine levels were on average lower in the treated group [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another trial in 818 participants with elevated serum homocysteine who were between 50 and 70 years of age found that folate supplementation (800 mcg daily) for three years was associated with decreased homocysteine levels (26 percent) and improved performance on two of five cognitive measures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/26\">",
"       26",
"      </a>",
"      ]. Cognitive outcome was not a primary outcome of this trial, which also looked at a number of other endpoints, making it likely that a positive result was due to chance alone.",
"     </li>",
"     <li>",
"      In a trial of 299 hypertensive men aged 75 years and older, supplementation with vitamin B12,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      , and vitamin B6 for two years was not associated with improved cognitive function or reduced risk of cognitive impairment or dementia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is some evidence that vitamin D deficiency is associated with cognitive impairment in older adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/28\">",
"     28",
"    </a>",
"    ]. The effect appears to be small and of uncertain clinical significance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/22/36202?source=see_link\">",
"     \"Risk factors for dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pending the results of a controlled intervention study, there is no compelling reason to prescribe vitamin D supplementation for the purpose of preventing cognitive decline or dementia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIET",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of cohort studies have examined a possible relationship between dietary components and risk of AD and other dementias. However, because of the inherent confounders in epidemiological studies, specific recommendations regarding diet in the prevention of dementia will require a randomized controlled design, and at present, no conclusive recommendations can be made [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/2\">",
"     2",
"    </a>",
"    ]. As an example, high dietary intake of fish and omega-3 fatty acids may decrease the risk of cognitive impairment and Alzheimer disease (AD), while cholesterol and fatty acid intake may increase the risk, but the evidence is conflicting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Low cholesterol and low fat diets",
"    </span>",
"   </p>",
"   <p>",
"    In large prospective cohort studies, as well as cross-sectional studies, higher rates of cognitive decline",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    incident dementia have been associated with higher dietary intake of saturated fats, transunsaturated fats, or cholesterol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]; others have not found an association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/32\">",
"     32",
"    </a>",
"    ]. This has led to studies measuring the effect of cholesterol-lowering therapies, specifically the statin drugs, on the risk of dementia, which have also had mixed results (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Statins'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30662690\">",
"    <span class=\"h2\">",
"     Omega-3 fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential healthful affects of dietary intake of fish and omega-3 fatty acids on the risk of dementia as well as cardiovascular disease and other health conditions have been studied as well. The findings have been mixed, but most large, longitudinal studies have shown a benefit for higher fish consumption on the risk of dementia, cognitive decline, or the accumulation of white matter abnormalities on brain MRI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/30,33-37\">",
"     30,33-37",
"    </a>",
"    ], with some exceptions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/32\">",
"     32",
"    </a>",
"    ]. Interest has focused on specific omega-3 fatty acids, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the Framingham study, individuals with the top quartile levels of DHA measured at baseline had lower rates of incident dementia over nine years of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/38\">",
"     38",
"    </a>",
"    ]. Another prospective study associated higher plasma levels of EPA (but not DHA) with lower rates of hippocampal atrophy over four years of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/39\">",
"     39",
"    </a>",
"    ]. In a cross-sectional study, higher levels of &omega;-3 polyunsaturated fatty acid intake (as assessed through dietary surveys) were associated with lower levels of plasma beta-amyloid, a biomarker of AD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the above-mentioned studies are observational and subject to bias. It is possible that any apparent protective effects of dietary fish intake are due to residual confounding from factors such as education and economic status or due to the effects of fish intake on other processes such as vascular disease. No randomized study has examined the effect of dietary intake of fish and omega-3 fatty acids on the risk of dementia. A meta-analysis of three trials which studied the impact of omega-3 supplementation on cognitive performance found no effect of treatment after 6 to 40 months of supplementation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Moreover, DHA supplementation did not appear to be helpful in the treatment of patients with mild to moderate AD in one randomized trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33865?source=see_link&amp;anchor=H1135167#H1135167\">",
"     \"Treatment of dementia\", section on 'Omega-3 fatty acids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Fruit and vegetables",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diet high in fruits and vegetables is supported by the health benefits of reduced cardiovascular risk. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31641?source=see_link\">",
"     \"Healthy diet in adults\"",
"    </a>",
"    .) High fruit and vegetable intake may also decrease the risk of cognitive decline, but the data are less clear. One cohort study of 1836 older Japanese-Americans found that consumption of fruit and vegetable juices was associated with decreased incident dementia over seven to nine years of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/43\">",
"     43",
"    </a>",
"    ]. In another large population-based cohort of 8085 individuals, daily consumption of fruit and vegetables was associated with decreased risk of incident dementia (HR = 0.72) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/36\">",
"     36",
"    </a>",
"    ]. Two large, prospective, observational studies found that high consumption of vegetables, but not fruits, was associated with less cognitive decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Earlier cross-sectional studies reported that both fruit and vegetable intake were associated with improved cognitive performance in elderly subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Mediterranean diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no single Mediterranean diet, but such diets are typically high in fruits, vegetables, whole grains, beans, nuts, and seeds and include olive oil as an important source of fat. There are typically low to moderate amounts of fish, poultry, and dairy products, and there is little red meat.",
"   </p>",
"   <p>",
"    Several studies have used dietary questionnaires to assess and quantify adherence to the diet in different population cohorts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/48-53\">",
"     48-53",
"    </a>",
"    ]. These have found that patients who were most adherent to the diet had a lower incidence of mild cognitive impairment and AD and slower rates of cognitive decline compared with those who did not follow this diet. These studies are subject to the same limitations discussed above regarding confounding from economic and educational factors. In addition, the use of questionnaires to assess diet may be problematic given that individuals at risk for AD may have baseline mild cognitive impairment.",
"   </p>",
"   <p>",
"    Further support for a beneficial effect of the Mediterranean diet on the course of AD comes from a community-based study of 192 patients with AD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/54\">",
"     54",
"    </a>",
"    ]. Incremental reductions in AD-related mortality were noted in higher diet adherence groups suggesting a possible dose-response effect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H533920\">",
"    <span class=\"h2\">",
"     Other nutrients and dietary supplements",
"    </span>",
"   </p>",
"   <p>",
"    In the Nurses&rsquo; Health Study, dietary intake of berries high in flavonoids (eg, blueberries, strawberries) was associated with slower rates of cognitive decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/55\">",
"     55",
"    </a>",
"    ]. Flavonoids are believed to have antioxidant and anti-inflammatory actions that may contribute to a protective effect.",
"   </p>",
"   <p>",
"    Isoflavone-rich soy protein supplementation did not improve cognitive outcomes after 2.5 years in a randomized trial in 350 healthy postmenopausal women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H267642324\">",
"    <span class=\"h1\">",
"     ALCOHOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;While there is some evidence that light to moderate alcohol use may be protective, this is largely based on observational studies and the findings have been inconsistent. These data are presented in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=see_link&amp;anchor=H28#H28\">",
"     \"Overview of the risks and benefits of alcohol consumption\", section on 'Dementia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LIFESTYLE AND ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accumulating evidence, mainly from longitudinal observational studies, suggests that higher levels of physical and mental activity as well as social interaction may help maintain cognitive function during aging. However, methodologic issues in observational trials make it difficult to be certain of the exact relationship between exercise, physical fitness, cognitive leisure activities, and dementia. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/22/36202?source=see_link&amp;anchor=H14#H14\">",
"     \"Risk factors for dementia\", section on 'Lifestyle and activity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study randomly assigned 170 older adults (&gt; 49 years) to an",
"    <span class=\"nowrap\">",
"     education/usual",
"    </span>",
"    care and to a 24-week home-based physical activity program [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/57\">",
"     57",
"    </a>",
"    ]. After 18 months, analysis of cognition in the 138 participants who completed the program demonstrated a modest benefit for the physical activity intervention.",
"   </p>",
"   <p>",
"    Various cognitive interventions including memory training, the use of external memory cues, and organizational aids have been shown to improve function in healthy older adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]. One study randomized 2832 older adults to one of three cognitive interventions or a control group, and found that a 10-week training program in inductive reasoning (but not in verbal memory or speed of processing) resulted in improved performance on the Instrumental Activities of Daily Living that was sustained at five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the current data and biologic plausibility regarding the relationship between lifestyle and dementia risk (as well as other health benefits), it seems reasonable to encourage patients to maintain or increase physical activity, exercise, cognitive leisure activities, and social interaction. &nbsp;However, it is not known whether these interventions effectively reduce dementia risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC TREATMENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antihypertensive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertension appears to be associated with an increased risk of both vascular dementia and Alzheimer disease (AD), but the effect of antihypertensive treatment on reducing risk is uncertain. One analysis estimated based upon the prevalence of hypertension and the relative risk for dementia, lowering the prevalence of hypertension by 25 percent could reduce the incidence of AD by nearly 100,000 cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/22/36202?source=see_link&amp;anchor=H11#H11\">",
"     \"Risk factors for dementia\", section on 'Hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, randomized, controlled studies have yielded conflicting data regarding the effect of antihypertensive therapy on dementia prevention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/62-71\">",
"     62-71",
"    </a>",
"    ]. Some of this conflict may be explained by the length of follow-up in these trials",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the type of antihypertensive therapy used. Also, some trials had significant number of patients who were lost to follow-up",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    had a number of patients allocated to placebo who were on active treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/71\">",
"     71",
"    </a>",
"    ]. Limited studies do not support an advantage of one antihypertensive agent over another for this indication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/72\">",
"     72",
"    </a>",
"    ]. As an example, cognitive impairment was a secondary outcome measure in two large trials of blood pressure therapy in cardiovascular patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/70\">",
"     70",
"    </a>",
"    ]. In the ONTARGET trial, similar rates of cognitive impairment occurred in patients allocated to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/38/27239?source=see_link\">",
"     telmisartan",
"    </a>",
"    , or combination therapy, and in the TRANSCEND trial similar rates were seen in patients allocated telmisartan or placebo.",
"   </p>",
"   <p>",
"    Until more data are available, firm conclusions regarding antihypertensive treatment for prevention of dementia or cognitive impairment cannot be made [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/73\">",
"     73",
"    </a>",
"    ]. However, there are enough other reasons to treat patients with hypertension that the prevention of dementia alone is unlikely to influence therapeutic decisions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cholinesterase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholinesterase inhibitors have been studied in the prevention of dementia in patients with mild cognitive impairment. This topic is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/33/26138?source=see_link&amp;anchor=H15#H15\">",
"     \"Mild cognitive impairment: Prognosis and treatment\", section on 'Acetylcholinesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hormone therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic studies suggested that estrogen replacement might prevent dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/74-77\">",
"     74-77",
"    </a>",
"    ]. However, data from the Women's Health Initiative (WHI) and the WHI Memory Study (WHIMS) do not support these observations, and suggest that estrogen replacement does not protect against dementia and may increase the risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/78-81\">",
"     78-81",
"    </a>",
"    ]. The impact on dementia of HRT use in younger postmenopausal women is not known. However, HRT is not recommended for the prevention of dementia. This topic is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41975?source=see_link\">",
"     \"Estrogen and cognitive function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hormone dehydroepiandrosterone (DHEA) is produced by the adrenal gland; peak production and serum concentrations occur in young adulthood and decline progressively thereafter. DHEA has been proposed to have many potential benefits in retarding diseases associated with aging, including cognitive impairment and dementia. A systematic review of three small clinical trials of DHEA concluded that the data did not support a benefit for DHEA on cognitive function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/82\">",
"     82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/263?source=see_link\">",
"     \"Dehydroepiandrosterone and its sulfate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     NSAID therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some epidemiologic studies, but not others, have suggested that nonsteroidal antiinflammatory drugs (NSAIDs) protect against the development of AD and cognitive decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/83-95\">",
"     83-95",
"    </a>",
"    ], possibly by lowering levels of amyloidogenic Abeta42 protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/96-99\">",
"     96-99",
"    </a>",
"    ]. Conflicting results regarding their efficacy may be due in part to the timing and duration of NSAID use, to differences in tracking NSAID use, and to the ApoE genotype status of the participants. Their use is not currently supported by randomized clinical trials.",
"   </p>",
"   <p>",
"    The duration, dose, and timing of NSAID use may be important factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of cohort and case-control studies found a pooled relative risk (RR) of AD among NSAID users of 0.72 (95% CI 0.56-0.94); the RR among short, intermediate, and long-term users was 0.95 (CI 0.70-1.29), 0.83 (CI 0.65-1.06), and 0.27 (0.13-0.58) respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/90\">",
"       90",
"      </a>",
"      ]. The RR among",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      users was 0.87 (CI 0.70-1.07). In one of the larger observational studies, computerized pharmacy records of 6989 people aged &gt;55 years found that long-term NASID use protected against the development of AD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/89\">",
"       89",
"      </a>",
"      ]. With relative risk of AD of 0.95 in patients who had used NSAIDs for one month or less, 0.83 in patients who had used NSAIDs for more than one but less than 24 months, and 0.20 in patients who had used NSAIDs for 24 months or more.",
"     </li>",
"     <li>",
"      In the latter study, most of the NSAID effect in the long-term users was attributed to therapy two or more years before the onset of dementia, suggesting that there may be a critical period during which NSAID use is protective [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/89\">",
"       89",
"      </a>",
"      ]. This was also the finding of the Cache County, UT study in which NSAID use in midlife rather than late life was associated with less severe cognitive decline over eight years of follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/92\">",
"       92",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another population-based cohort study found that heavy NSAID use in late life may be associated with an increased rather than decreased risk of AD (HR = 1.7) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/100\">",
"       100",
"      </a>",
"      ]. In a subset of this cohort with autopsy data, the burden of neuritic plaque was associated a higher cumulative use of NSAIDs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/101\">",
"       101",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      No preferential benefit was found for those NSAIDS which are reported to selectively reduce Abeta42 (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"       ibuprofen",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/17/44312?source=see_link\">",
"       sulindac",
"      </a>",
"      ) compared with those which do not (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/43/43705?source=see_link\">",
"       naproxen",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/35/13881?source=see_link\">",
"       etodolac",
"      </a>",
"      ), according to one large cohort study and the pooled results of six other cohort studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/93,102\">",
"       93,102",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A large randomized trial studied the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/43/43705?source=see_link\">",
"     naproxen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    , and placebo in the prevention of AD in 2528 individuals &gt;70 years with a history of at least one family member with AD-like dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/103\">",
"     103",
"    </a>",
"    ]. Imperfect screening had led to the enrollment of 53 persons with premorbid dementia or mild cognitive impairment. Analysis of the study population with these individuals excluded, after two years of follow-up, demonstrated that AD risk was actually increased in both active treatment groups (HR=4.1, 3.6). Other measures of cognition were not improved and were possibly worse in the treated groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/104\">",
"     104",
"    </a>",
"    ]. The trial was stopped early because of an increased risk of myocardial infarction in patients treated with naproxen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/103\">",
"     103",
"    </a>",
"    ]. Long-term use of certain COX-2 inhibitor inhibitors has also been associated with an increased risk of cardiovascular events. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another large, randomized study of 6377 participants found that older women randomly assigned to low dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    had similar rates of cognitive decline compared to the placebo-treated group after more than 5 years of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/105\">",
"     105",
"    </a>",
"    ]. Similarly, a 5-year study of low dose aspirin in 3350 individuals over 50 years found no effective of treatment on cognitive test scores [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cyclooxygenase-2 (COX-2) inhibitors and NSAIDs should not be used for the treatment or prevention of dementia or cognitive impairment at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Statins",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been some interest in, but no established role for the use of HMG CoA reductase inhibitors (statins) in the prevention of dementia. Statins also have no currently defined role in the treatment of dementia or AD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33865?source=see_link&amp;anchor=H9546717#H9546717\">",
"     \"Treatment of dementia\", section on 'Statins'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Retrospective studies have suggested that statins may prevent the development of dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/107-111\">",
"     107-111",
"    </a>",
"    ]. One of the largest of these studies, involving 6992 participants in the Rotterdam study, found that the use of statins was associated with a decreased risk of AD (HR 0.57) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/110\">",
"     110",
"    </a>",
"    ]. This benefit was similar in lipophilic and hydrophilic statins and was not observed in patients taking non-statin cholesterol lowering drugs.",
"   </p>",
"   <p>",
"    This potential effect could be based upon one or more of the following mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A direct association between amyloid processing and cholesterol in the brain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/112,113\">",
"       112,113",
"      </a>",
"      ]. As an example, a combined in vitro and guinea pig study found that",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/36/17993?source=see_link\">",
"       simvastatin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42312?source=see_link\">",
"       lovastatin",
"      </a>",
"      reduced intracellular and extracellular levels of amyloid peptides Abeta40 and Abeta42 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/114\">",
"       114",
"      </a>",
"      ]. Statins appear to reduce amyloid burden by promoting the nonamyloidogenic alpha-secretase pathway of amyloid precursor protein metabolism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/115-117\">",
"       115-117",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An indirect effect via decreasing the risk of stroke, since even small cerebral infarcts worsen the severity of AD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/118\">",
"       118",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30682?source=see_link\">",
"       \"Secondary prevention of stroke: Risk factor reduction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On the other hand, the relationship could be spurious based upon an indication bias; physicians might be less likely to prescribe a statin to a patient with early, as yet undiagnosed, AD, or to discontinue its use in a patient with more severe dementia.",
"   </p>",
"   <p>",
"    Prospective observational studies using variable methods, patient populations, and outcome measures have yielded somewhat mixed results regarding the efficacy of current or past statin use in reducing the incidence of dementia, the degree of age-related cognitive decline, or the neuropathologic burden of Alzheimer pathology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/119-127\">",
"     119-127",
"    </a>",
"    ]. In some studies, but not in others, the observed efficacy was linked to lipid-lowering [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/121,123\">",
"     121,123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from two large randomized controlled clinical trials of patients with cardiovascular disease did not show any protective effect of statins for cognition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/128-130\">",
"     128-130",
"    </a>",
"    ], but these studies were not designed to identify dementia or AD, and treatment was started relatively late in life, possibly after the pathogenic process was already in progress. Randomized controlled clinical trials with incident dementia or cognitive decline as a primary endpoint are needed to determine the effect of statins on the risk of dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to the above observations suggesting that statins may have a role in the prevention of dementia, other studies have suggested that statins may cause cognitive dysfunction in selected patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/35/32314?source=see_link&amp;anchor=H15#H15\">",
"     \"Statins: Actions, side effects, and administration\", section on 'Behavioral and cognitive'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Ginkgo biloba",
"    </span>",
"    &nbsp;&mdash;&nbsp;A multi-center, randomized, double-blind placebo-controlled study of Ginkgo biloba in 3069 older adults (75 years or older) found that after a median six years of follow-up, treatment was not effective in reducing the incidence of AD or all-cause dementia and did not slow cognitive decline in individuals with either normal cognition or mild cognitive impairment at baseline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/132,133\">",
"     132,133",
"    </a>",
"    ]. Similarly, in another clinical trial of 2854 patients aged 70 years and older with memory complaints, treatment with gingko biloba was not associated with a reduced incidence of dementia after five years of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/25/41369/abstract/134\">",
"     134",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/28/11720?source=see_link\">",
"     \"Clinical use of ginkgo biloba\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/37/14934?source=see_link\">",
"       \"Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most data on preventing dementia come from observational studies. Prospective studies and randomized controlled trials have not shown an overall benefit from cholinesterase inhibitors, vitamin E, NSAIDS, or estrogen replacement. Ongoing studies should help to clarify the role of statins.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We do not recommend vitamin E in patients at high risk of developing Alzheimer disease (AD) because of the evidence that vitamin E supplementation increases the risk for all-cause mortality and there is no convincing evidence that it affects the risk of developing AD (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"       \"Vitamin supplementation in disease prevention\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Although there is observational evidence that NSAIDs are protective for dementia, the limited clinical trial evidence is not favorable. We do not recommend their use even in patients at high risk for AD (ie, those with very strong family histories) because of the possible increased risk of cardiovascular events associated with NSAIDs and COX-2 inhibitors.",
"     </li>",
"     <li>",
"      We encourage all patients, especially those with early dementia or at higher risk for dementia, to maintain or increase physical activity and exercise as long as there are no contraindications. Similarly, we encourage cognitive leisure activities and social interaction for as long as these are feasible. However, we recognize that these lifestyle factors remain unproven as a means of preventing dementia.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/1\">",
"      Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011; 10:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/2\">",
"      Daviglus ML, Bell CC, Berrettini W, et al. National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med 2010; 153:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/3\">",
"      Daviglus ML, Plassman BL, Pirzada A, et al. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol 2011; 68:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/4\">",
"      Behl C. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 1997; 290:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/5\">",
"      Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000; 71:621S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/6\">",
"      Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am J Clin Nutr 2000; 71:630S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/7\">",
"      Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997; 336:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/8\">",
"      Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/9\">",
"      Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000; 54:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/10\">",
"      Commenges D, Scotet V, Renaud S, et al. Intake of flavonoids and risk of dementia. Eur J Epidemiol 2000; 16:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/11\">",
"      Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287:3223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/12\">",
"      Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287:3230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/13\">",
"      Foley DJ, White LR. Dietary intake of antioxidants and risk of Alzheimer disease: food for thought. JAMA 2002; 287:3261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/14\">",
"      Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003; 60:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/15\">",
"      Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004; 61:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/16\">",
"      Dunn JE, Weintraub S, Stoddard AM, Banks S. Serum alpha-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairment. Neurology 2007; 68:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/17\">",
"      Devore EE, Grodstein F, van Rooij FJ, et al. Dietary antioxidants and long-term risk of dementia. Arch Neurol 2010; 67:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/18\">",
"      Yaffe K, Clemons TE, McBee WL, et al. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology 2004; 63:1705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/19\">",
"      Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352:2379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/20\">",
"      Kang JH, Cook N, Manson J, et al. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006; 166:2462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/21\">",
"      Kang JH, Cook NR, Manson JE, et al. Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. Circulation 2009; 119:2772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/22\">",
"      Grodstein F, Kang JH, Glynn RJ, et al. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med 2007; 167:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/23\">",
"      Yaffe K. Antioxidants and prevention of cognitive decline: does duration of use matter? Arch Intern Med 2007; 167:2167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/24\">",
"      Luchsinger JA, Tang MX, Miller J, et al. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007; 64:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/25\">",
"      McMahon JA, Green TJ, Skeaff CM, et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354:2764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/26\">",
"      Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007; 369:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/27\">",
"      Ford AH, Flicker L, Alfonso H, et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology 2010; 75:1540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/28\">",
"      Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 2012; 79:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/29\">",
"      Morris MC, Evans DA, Bienias JL, et al. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004; 62:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/30\">",
"      Kalmijn S, van Boxtel MP, Ock&eacute; M, et al. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004; 62:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/31\">",
"      Okereke OI, Rosner BA, Kim DH, et al. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol 2012; 72:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/32\">",
"      Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology 2002; 59:1915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/33\">",
"      Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/34\">",
"      Huang TL, Zandi PP, Tucker KL, et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 2005; 65:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/35\">",
"      Morris MC, Evans DA, Tangney CC, et al. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005; 62:1849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/36\">",
"      Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007; 69:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/37\">",
"      Virtanen JK, Siscovick DS, Longstreth WT Jr, et al. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 2008; 71:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/38\">",
"      Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006; 63:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/39\">",
"      Samieri C, Maillard P, Crivello F, et al. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology 2012; 79:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/40\">",
"      Gu Y, Schupf N, Cosentino SA, et al. Nutrient intake and plasma &beta;-amyloid. Neurology 2012; 78:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/41\">",
"      Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012; 6:CD005379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/42\">",
"      Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010; 304:1903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/43\">",
"      Dai Q, Borenstein AR, Wu Y, et al. Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med 2006; 119:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/44\">",
"      Morris MC, Evans DA, Tangney CC, et al. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 2006; 67:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/45\">",
"      Kang JH, Ascherio A, Grodstein F. Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol 2005; 57:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/46\">",
"      Ortega RM, Requejo AM, Andr&eacute;s P, et al. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997; 66:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/47\">",
"      Lee L, Kang SA, Lee HO, et al. Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health 2001; 115:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/48\">",
"      Scarmeas N, Stern Y, Tang MX, et al. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006; 59:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/49\">",
"      Stavitsky K, Brickman AM, Scarmeas N, et al. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 2006; 63:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/50\">",
"      Scarmeas N, Stern Y, Mayeux R, et al. Mediterranean diet and mild cognitive impairment. Arch Neurol 2009; 66:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/51\">",
"      Scarmeas N, Luchsinger JA, Schupf N, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009; 302:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/52\">",
"      F&eacute;art C, Samieri C, Rondeau V, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009; 302:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/53\">",
"      Gu Y, Nieves JW, Stern Y, et al. Food combination and Alzheimer disease risk: a protective diet. Arch Neurol 2010; 67:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/54\">",
"      Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology 2007; 69:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/55\">",
"      Devore EE, Kang JH, Breteler MM, Grodstein F. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol 2012; 72:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/56\">",
"      Henderson VW, St John JA, Hodis HN, et al. Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial. Neurology 2012; 78:1841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/57\">",
"      Lautenschlager NT, Cox KL, Flicker L, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008; 300:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/58\">",
"      Verhaeghen P, Marcoen A, Goossens L. Improving memory performance in the aged through mnemonic training: a meta-analytic study. Psychol Aging 1992; 7:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/59\">",
"      Stuss DT, Robertson IH, Craik FI, et al. Cognitive rehabilitation in the elderly: a randomized trial to evaluate a new protocol. J Int Neuropsychol Soc 2007; 13:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/60\">",
"      Troyer, AK. Improving memory, knowledge, satisfaction, and functioning via an education and intervention program for older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2001; 8:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/61\">",
"      Willis SL, Tennstedt SL, Marsiske M, et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006; 296:2805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/62\">",
"      Rigaud AS, Seux ML, Staessen JA, et al. Cerebral complications of hypertension. J Hum Hypertens 2000; 14:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/63\">",
"      Birkenh&auml;ger WH, Forette F, Seux ML, et al. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med 2001; 161:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/64\">",
"      Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002; 162:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/65\">",
"      Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265:3255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/66\">",
"      Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 1996; 312:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/67\">",
"      Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/68\">",
"      Saxby BK, Harrington F, Wesnes KA, et al. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology 2008; 70:1858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/69\">",
"      Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/70\">",
"      Anderson C, Teo K, Gao P, et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2011; 10:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/71\">",
"      McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009; :CD004034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/72\">",
"      Haag MD, Hofman A, Koudstaal PJ, et al. Duration of antihypertensive drug use and risk of dementia: A prospective cohort study. Neurology 2009; 72:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/73\">",
"      McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006; :CD004034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/74\">",
"      Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997; 48:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/75\">",
"      Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/76\">",
"      Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/77\">",
"      LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001; 285:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/78\">",
"      Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289:2651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/79\">",
"      Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291:2947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/80\">",
"      Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291:2959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/81\">",
"      Schneider LS. Estrogen and dementia: insights from the Women's Health Initiative Memory Study. JAMA 2004; 291:3005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/82\">",
"      Grimley Evans J, Malouf R, Huppert F, van Niekerk JK. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database Syst Rev 2006; :CD006221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/83\">",
"      Broe GA, Grayson DA, Creasey HM, et al. Anti-inflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol 2000; 57:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/84\">",
"      Beard CM, Waring SC, O'Brien PC, et al. Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984. Mayo Clin Proc 1998; 73:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/85\">",
"      in 't Veld BA, Launer LJ, Hoes AW, et al. NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging 1998; 19:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/86\">",
"      Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997; 48:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/87\">",
"      Zandi PP, Anthony JC, Hayden KM, et al. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 2002; 59:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/88\">",
"      de Craen AJ, Gussekloo J, Vrijsen B, Westendorp RG. Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol 2005; 161:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/89\">",
"      in t' Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001; 345:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/90\">",
"      Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 2003; 327:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/91\">",
"      Kang JH, Grodstein F. Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women. Neurology 2003; 60:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/92\">",
"      Hayden KM, Zandi PP, Khachaturian AS, et al. Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology 2007; 69:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/93\">",
"      Szekely CA, Breitner JC, Fitzpatrick AL, et al. NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology 2008; 70:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/94\">",
"      Vlad SC, Miller DR, Kowall NW, Felson DT. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 2008; 70:1672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/95\">",
"      Arvanitakis Z, Grodstein F, Bienias JL, et al. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology 2008; 70:2219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/96\">",
"      Zhou Y, Su Y, Li B, et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science 2003; 302:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/97\">",
"      Weggen S, Eriksen JL, Das P, et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 2001; 414:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/98\">",
"      Lle&oacute; A, Berezovska O, Herl L, et al. Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med 2004; 10:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/99\">",
"      Kukar T, Murphy MP, Eriksen JL, et al. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 2005; 11:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/100\">",
"      Breitner JC, Haneuse SJ, Walker R, et al. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 2009; 72:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/101\">",
"      Sonnen JA, Larson EB, Walker RL, et al. Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology 2010; 75:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/102\">",
"      Szekely CA, Green RC, Breitner JC, et al. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 2008; 70:2291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/103\">",
"      ADAPT Research Group, Lyketsos CG, Breitner JC, et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007; 68:1800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/104\">",
"      ADAPT Research Group, Martin BK, Szekely C, et al. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol 2008; 65:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/105\">",
"      Kang JH, Cook N, Manson J, et al. Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ 2007; 334:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/106\">",
"      Price JF, Stewart MC, Deary IJ, et al. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ 2008; 337:a1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/107\">",
"      Wolozin B, Kellman W, Ruosseau P, et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/108\">",
"      Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000; 356:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/109\">",
"      Rodriguez EG, Dodge HH, Birzescu MA, et al. Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study. J Am Geriatr Soc 2002; 50:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/110\">",
"      Haag MD, Hofman A, Koudstaal PJ, et al. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2009; 80:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/111\">",
"      Li G, Shofer JB, Rhew IC, et al. Age-varying association between statin use and incident Alzheimer's disease. J Am Geriatr Soc 2010; 58:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/112\">",
"      Haley RW, Dietschy JM. Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer disease? Arch Neurol 2000; 57:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/113\">",
"      Vega GL, Weiner MF, Lipton AM, et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol 2003; 60:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/114\">",
"      Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 2001; 98:5856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/115\">",
"      Simons M, Keller P, De Strooper B, et al. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 1998; 95:6460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/116\">",
"      Kojro E, Gimpl G, Lammich S, et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A 2001; 98:5815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/117\">",
"      Pedrini S, Carter TL, Prendergast G, et al. Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med 2005; 2:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/118\">",
"      Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/119\">",
"      Li G, Higdon R, Kukull WA, et al. Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 2004; 63:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/120\">",
"      Rea TD, Breitner JC, Psaty BM, et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 2005; 62:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/121\">",
"      Dufouil C, Richard F, Fi&eacute;vet N, et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005; 64:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/122\">",
"      Bernick C, Katz R, Smith NL, et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 2005; 65:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/123\">",
"      Masse I, Bordet R, Deplanque D, et al. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005; 76:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/124\">",
"      Li G, Larson EB, Sonnen JA, et al. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 2007; 69:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/125\">",
"      Szwast SJ, Hendrie HC, Lane KA, et al. Association of statin use with cognitive decline in elderly African Americans. Neurology 2007; 69:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/126\">",
"      Arvanitakis Z, Schneider JA, Wilson RS, et al. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 2008; 70:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/127\">",
"      Cramer C, Haan MN, Galea S, et al. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 2008; 71:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/128\">",
"      Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/129\">",
"      Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/130\">",
"      McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev 2009; :CD003160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/131\">",
"      Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 2011; 68:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/132\">",
"      DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008; 300:2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/133\">",
"      Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009; 302:2663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/25/41369/abstract/134\">",
"      Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012; 11:851.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5075 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-B6AD6E7C64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41369=[""].join("\n");
var outline_f40_25_41369=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VITAMIN SUPPLEMENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Antioxidant vitamins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Vitamins B6, B12, and folate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Low cholesterol and low fat diets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30662690\">",
"      Omega-3 fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Fruit and vegetables",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Mediterranean diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H533920\">",
"      Other nutrients and dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H267642324\">",
"      ALCOHOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LIFESTYLE AND ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PHARMACOLOGIC TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antihypertensive therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cholinesterase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      NSAID therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Statins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Ginkgo biloba",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1914?source=related_link\">",
"      Clinical features and diagnosis of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/33/27162?source=related_link\">",
"      Clinical manifestations and diagnosis of Alzheimer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/28/11720?source=related_link\">",
"      Clinical use of ginkgo biloba",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/263?source=related_link\">",
"      Dehydroepiandrosterone and its sulfate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41975?source=related_link\">",
"      Estrogen and cognitive function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/57/37786?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31641?source=related_link\">",
"      Healthy diet in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/33/26138?source=related_link\">",
"      Mild cognitive impairment: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=related_link\">",
"      Overview of the risks and benefits of alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/37/14934?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/22/36202?source=related_link\">",
"      Risk factors for dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30682?source=related_link\">",
"      Secondary prevention of stroke: Risk factor reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/35/32314?source=related_link\">",
"      Statins: Actions, side effects, and administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/55/10104?source=related_link\">",
"      Treatment and prevention of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33865?source=related_link\">",
"      Treatment of dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=related_link\">",
"      Vitamin supplementation in disease prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_25_41370="ECG bundle branch reentrant ventricular tachcardia";
var content_f40_25_41370=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67679%7ECARD%2F77331%7ECARD%2F66372%7ECARD%2F80017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67679%7ECARD%2F77331%7ECARD%2F66372%7ECARD%2F80017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 549px\">",
"   <div class=\"ttl\">",
"    Surface 12-lead ECG in bundle branch reentrant ventricular tachcardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 529px; height: 395px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: 12 lead ECG during sinus rhythm; there is a left bundle branch block-type intraventricular conduction delay. Right panel: 12 lead ECG during ventricular tachycardia; there is a remarkable similarity in QRS morphology during VT and sinus rhythm. The HV interval during sinus rhythm was 65 msec, suggesting underlying His-Purkinje conduction disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study of bundle branch reentrant ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are five surface ECG leads (I, II, aVF, V1, V6) and intracardiac recordings from the high right atrium (HRA3-4), His bundle region (HBE1-2), and the right ventricular apex (RVA3-4). The atrial and ventricular (V) electrograms are dissociated, confirming a ventricular tachycardia; however, a His bundle depolarization (H) precedes each ventricular electrogram. Further testing confirmed the diagnosis of bundle branch reentrant ventricular tachycardia (BBRVT), a macroreentrant ventricular tachycardia involving the left and right bundle branches. During typical BBRVT, the wavefront goes down the right bundle, across the interventricular septum, and then retrograde up the left bundle, with passive retrograde activation of the His bundle. Since both bundle branches are necessary parts of the macroreentry circuit, catheter ablation of the right bundle branch is curative.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 556px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study in a patient with bundle branch reentrant ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 536px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are five surface ECG leads (I, II, aVF, V1, V6) and intracardiac recordings from the His bundle region (HBE2-3,1-2), the right ventricular apex (RVA3-4), and a mapping catheter (USER1) positioned distal to the His catheter along the RV septum to record a right bundle potential (arrow). The right bundle potential was recorded 30 ms after the His potential (H).",
"    <div class=\"footnotes\">",
"     A: atrial electrogram; V: ventricular electrogram.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG tracings during radiofrequency catheter ablation of the right bundle branch in a patient with BBRVT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 364px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are five surface ECG leads (I, II, aVF, V1, V6) and intracardiac recordings from the His bundle region (HBE2-3,1-2), the right ventricular apex (RVA3-4), and a mapping catheter (USER1) positioned distal to the His catheter along the RV septum. Application of radiofrequency (RF) energy to the tip of the mapping catheter causes two accelerated beats with a typical left bundle branch block (LBBB) morphology (black arrow), likely from heating and activating the right bundle branch. After these beats, complete right bundle branch block (RBBB) is present (red arrow), as evidenced by the change in QRS morphology, particularly in lead V1. Following right bundle branch ablation, the HV interval increased to 105 ms, though no infranodal A-V block was noted. Right bundle branch reentrant tachycardia was no longer inducible. A permanent pacemaker was placed becaued of the markedly prolonged HV interval.",
"    <div class=\"footnotes\">",
"     H: His bundle electrogram; A: atrial electrogram; V: ventricular electrogram.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41370=[""].join("\n");
var outline_f40_25_41370=null;
var title_f40_25_41371="Infertility history";
var content_f40_25_41371=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53077&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53077&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The infertility history",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Ovulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Menstrual regularity and presence of moliminal symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Home confirmation of ovulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Over-the-counter kits, basal body temperatures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Presence of other endocrine conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Thyroid disease, hyperprolactinemia, hyperandrogenemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptoms of premature menopause",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family history of infertility or premature ovarian failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tubal or uterine factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of pelvic inflammatory disease, endometriosis, or ectopic pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of pelvic adhesions or surgeries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tubal or uterine surgeries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uterine fibroids or congenital anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Male factor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Partner's medical history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Chronic illnesses, endocrine disease, orchiitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of testicular surgery or trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of prior paternity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other urologic or ejaculatory problems",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41371=[""].join("\n");
var outline_f40_25_41371=null;
var title_f40_25_41372="TS diagnostic criteria";
var content_f40_25_41372=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Revised diagnostic criteria for tuberous sclerosis complex",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Major features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Facial angiofibromas or forehead plaque",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Nontraumatic ungual or periungual fibroma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Hypomelanotic macules (three or more)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Shagreen patch (connective tissue nevus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Multiple retinal nodular hamartomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Glioneuronal hamartoma (cortical tuber)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Subependymal nodule",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Subpendymal giant cell atrocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. Cardiac rhabdomyoma, single or multiple",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10. Lymphangioleiomyomatosis",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11. Renal angiomyolipoma",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Minor features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Multiple, randomly distributed pits in dental enamel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Hamartomatous rectal polyps",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Bone cysts",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Cerebral white matter radial migration lines*",
"        <sup>",
"         &loz;&sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Gingival fibromas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Nonrenal hamartoma",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Retinal achromic patch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. \"Confetti\" skin lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. Multiple renal cysts",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Definite tuberous sclerosis complex:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Either two major features or one major feature plus two minor features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Probable tuberous sclerosis complex:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One major plus one minor feature",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Possible tuberous sclerosis complex:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Either one major feature or two or more minor features",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * When cerebral cortical dysplasia and cerebral white matter migration tracts occur together, they should be counted as one rather than two features of tuberous sclerosis.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     When both lymphangioleiomyomatosis and renal angiomyolipomas are present, other features of tuberous sclerosis should be present before a definite diagnosis is assigned.",
"     <br/>",
"     &Delta; Histologic confirmation is suggested.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Radiographic confirmation is sufficient.",
"     <br/>",
"     &sect; One panel member (MRG) felt strongly that three or more radial migration lines should constitute a major sign.",
"    </div>",
"    <div class=\"reference\">",
"     From: Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998; 13:624. Copyright &copy; 1998. Reprinted by permission of SAGE Publications.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41372=[""].join("\n");
var outline_f40_25_41372=null;
var title_f40_25_41373="Differential diagnosis acute knee pain athlete A";
var content_f40_25_41373=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76993%7EPEDS%2F58127&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76993%7EPEDS%2F58127&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of acute knee pain in the young athlete: part A",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mechanism of injury",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical Features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Anterior",
"pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"5\">",
"        ACL injury",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Twisting or hyperextension",
"       </td>",
"       <td>",
"        Sudden pain and giving way",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Often accompanied by MCL and/or meniscal injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unable to ambulate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemarthrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal anterior drawer, Lachman, or pivot shift test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inability to fully squat or duck waddle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"3\">",
"        Rupture of patellar",
"or quadriceps tendon",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Fall on partially flexed knee",
"       </td>",
"       <td>",
"        Instability with ambulation",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        May be associated with patellar fracture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Significant pain and swelling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Posterior pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"4\">",
"        PCL injury",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Direct force to anterior knee with the knee in flexion,",
"fall onto flexed knee with foot in plantar flexion; hyperflexion;",
"hyperextension (after rupture of ACL)",
"       </td>",
"       <td>",
"        Effusion within 24 hours",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Usually combined with other injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Limited range of motion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Instability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tibia in posterior position relative to femur",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Medial pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"4\">",
"        MCL injury",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Valgus force without rotation",
"       </td>",
"       <td>",
"        Localized pain, ecchymosis, swelling and stiffness",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Often accompanied by ACL injuries (in which case knee",
"dislocation must be considered)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain along course of ligament",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laxity with valgus stress in 30 degrees of knee flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laxity with valgus stress in 0 degrees of knee flexion",
"indicates concurrent ACL injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"8\">",
"        Medial meniscal tear",
"       </td>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        Twisting injury",
"       </td>",
"       <td>",
"        Usually able to ambulate, but weight bearing is limited",
"by pain",
"       </td>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Knee swelling and stiffness develop over 2 to 3 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mechanical symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medial pain with twisting or squatting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medial joint line tenderness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive McMurray test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive bounce home test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased range of motion",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ACL: anterior cruciate ligament; MCL: medical collateral ligament; PCL: Posterior cruciate ligament.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of acute knee pain in the young athlete: part B",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mechanism of injury",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical Features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Lateral",
"pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"5\">",
"        LCL injury",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Varus force",
"       </td>",
"       <td>",
"        Localized swelling and stiffness",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Associated with superficial peroneal nerve injuries,",
"chondral injuries, and medial meniscal injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Able to ambulate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Localized pain, swelling, ecchymosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain along course of ligament (examine in figure of 4",
"position)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laxity with varus stress and 30 degrees of knee flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"8\">",
"        Lateral",
"meniscal tear",
"       </td>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        Twisting injury",
"       </td>",
"       <td>",
"        Usually able to ambulate, but weight bearing is limited",
"by pain",
"       </td>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Knee swelling and stiffness develop over two to three days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mechanical symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lateral pain with twisting or squatting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lateral joint line",
"tenderness&nbsp;&nbsp;&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive McMurray test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive bounce home test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased range of motion",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LCL: Lateral collateral ligament.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41373=[""].join("\n");
var outline_f40_25_41373=null;
var title_f40_25_41374="Rheumatoid nodule chest xray";
var content_f40_25_41374=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rheumatoid nodule chest x-ray",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest x-ray demonstrating a cavitating rheumatoid nodule. The patient presented with pleuritic chest pain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Fiona R Lake, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41374=[""].join("\n");
var outline_f40_25_41374=null;
var title_f40_25_41375="Echocardiogram 5 chamber magnified view of AS";
var content_f40_25_41375=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/61369/5chaszoo_conv.mp4?title=Echocardiogram+5+chamber+magnified+view+of+AS\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Echocardiogram five chamber view of aortic stenosis with magnified view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 314px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnified image of the aortic valve from a five chamber view from a patient with aortic stenosis shows significant calcification of the aortic valve with markedly reduced leaflet mobility.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_25_41375=[""].join("\n");
var outline_f40_25_41375=null;
